Introduction {#s1}
============

RNAs fold into and interconvert between specific secondary and tertiary structures to perform a wealth of essential biological functions ([@bib4]; [@bib14]). In particular, medium-sized non-coding RNA (ncRNA) domains in the 100- to 300-nucleotide size range have been discovered to form specific tertiary structures for sensing intra-cellular metabolites, regulating gene expression, and catalyzing precise splicing events ([@bib67]; [@bib15]; [@bib55]; [@bib48]). Similarly functional behaviors may be carried out by the tens of thousands of ncRNA domains expressed in complex organisms ([@bib3]). High-resolution structure determination techniques such as crystallography, NMR, and cryo-electron microscopy are providing critical insights into ncRNA behavior but are challenged by the large sizes, conformational heterogeneity, and multiple functional states of most biological ncRNA domains ([@bib74]). As an alternative methodology, there is a rich history of specialized biochemical interrogation, phylogenetic analysis, and manual model building to achieve global 3D structures of ncRNAs, including the first discovered ribozymes ([@bib38]; [@bib46]; [@bib11]; [@bib37]; [@bib47]). These models have reached nanometer accuracies, comparable to the spacing between adjacent nucleotides (6 Å) and significantly smaller than the diameter of an RNA helix (23 Å). While not atomic accuracy, such models have guided visualization of how an ncRNA\'s motifs and helices interact to effect functions like catalysis and ligand binding, fueling powerful experiments and evolutionary insights ([@bib34]). However, the experimental and modeling methods underlying these classic, medium-resolution approaches have not been fully automated or accelerated.

Chemical mapping techniques, such as hydroxyl radical footprinting and SHAPE, ([@bib74]) combined with new computational tools ([@bib18]), offer a promising route for expanding medium-resolution 3D modeling to ncRNA sequences and states that remain uncharacterized and for eventually refining such models to high resolution using computation or focused experiments ([@bib29]). Chemical mapping data report on the solvent exposure or base-pairing propensity of each nucleotide and can guide ncRNA structure inference with computational modeling algorithms ([@bib23]; [@bib25]; [@bib33]). Recent advances have enhanced the throughput of chemical mapping analysis and the accuracy of ncRNA secondary structure determination, with high accuracy achieved by 'two-dimensional' methods that integrate systematic mutagenesis with high-throughput mapping (mutate-and-map, or M^2^), analogous to multidimensional NMR spectroscopy but at nucleotide length scales ([@bib41]; [@bib79]; [@bib25]; [@bib51]; [@bib36]; [@bib61]; [@bib66]). However, barriers remain in 3D modeling, even at the modest 1-nanometer resolution required to visualize helix-level structures, to assess structural heterogeneity, or to make hypotheses for ligand-binding sites or tertiary interactions that can be experimentally tested.

The state-of-the-art in ncRNA 3D structure modeling has been rigorously established by the 'RNA-puzzles' trials ([@bib22]; [@bib49]). These community-wide exercises provide stringent tests of available computational methods by challenging modelers to predict structures of ncRNA sequences that have been crystallized but whose structures have not been publicly released. The dissemination of SHAPE, DMS, hydroxyl radical footprinting, and M^2^ measurements for recent RNA-puzzles has enabled our and other groups to consistently achieve high-secondary structure prediction accuracies. Furthermore, computational integration of available data with the fragment assembly of RNA (FARNA) algorithm in Rosetta ([@bib18]) has led to tertiary structure models with accuracies of 1 nanometer or better (all-heavy-atom root-mean-squared-deviation, RMSD). Unfortunately, these computational methods still generate alternative 3D structures consistent with the available data. Out of the 5 to 10 different structures submitted by each participating modeling team for each puzzle, we and others have been unable to rank the models with correct tertiary helical arrangements as our top submissions, much less confidently assign accuracies to these models or select candidates for computationally expensive refinement. We report herein an experimental/computational advance that resolves this barrier of 1-nm resolution global structure determination.

While M^2^ efficiently infers Watson--Crick base pairs, the RNA-puzzles trials have exposed a critical need for rapid experimental methods to comprehensively determine nucleotide pairs that are not in direct atom--atom contact but are brought into nanometer-scale proximity by an ncRNA\'s tertiary structure. Such a method would be a nucleotide-resolution analog to nuclear Overhauser effect (NOE) NMR spectroscopy, which detects 'through-space' proximities between atoms that are not necessarily bonded. This problem prompted us to revisit a technique for discovering RNA tertiary proximities termed Multiplexed •OH (hydroxyl radical) Cleavage Analysis (MOHCA) ([@bib23]), which reports on the cleavage of nucleotides by hydroxyl radicals generated at sources 10--30 Å away that are tethered to other nucleotides. Unfortunately, the original protocol (renamed 'MOHCA-gel' herein) required specially synthesized 2′-NH~2~-2′-deoxy-α-thio-nucleotide triphosphates for random radical source introduction and on-demand backbone scission at co-introduced phosphorothioates; a customized two-dimensional gel electrophoresis setup; radioactive labeling for the readout; and multiple experiments with both 5′ and 3′ end-labeling to achieve reasonable signal-to-noise ([@bib23]). These factors prevented MOHCA-gel from entering routine use or being tested along with M^2^ in RNA-puzzles trials.

We hypothesized that the recent availability of tabletop deep sequencing would enable an accelerated and higher-precision 'MOHCA-seq' protocol and that these data would complement M^2^ and Rosetta to give a multidimensional chemical mapping (MCM) pipeline for routine use in ncRNA 3D structure characterization. Here, we present the development, benchmarks, and a blind test of the MCM methodology, followed by applications to detect preformed structure in ligand-free riboswitch aptamer states and a recently discovered human ncRNA regulon.

Results {#s2}
=======

Deep proximity maps of ncRNA 3D structure from single experiments {#s2-1}
-----------------------------------------------------------------

To complement the prior M^2^ method for secondary structure inference ([Figure 1A](#fig1){ref-type="fig"}) with tertiary proximity maps, we developed and tested the MOHCA-seq workflow, shown in [Figure 1B](#fig1){ref-type="fig"}. The workflow was designed to read out proximal nucleotide pairs by introducing radical sources at random locations into the RNA, creating radicals that initiate strand breaks at positions close in three dimensions to each source, and mapping the sequence positions of each strand break and its parent source. We randomly incorporated 2′-NH~2~-2′-dATP during transcription so that each RNA contained on average one or fewer modifications and then coupled these sites to isothiocyanobenzyl-Fe(III)•EDTA. We chose these reagents because they are commercially available and therefore can be readily acquired by other laboratories. These RNAs were purified and then folded in buffer containing 50 mM Na-HEPES pH 8.0, 10 mM MgCl~2~, and any ligands appropriate for the system (see below and 'Materials and methods'). After folding, RNAs were fragmented by activating the Fenton reaction at the backbone-tethered Fe(III) atoms using ascorbate as a reducing agent ([@bib23]). In the prior MOHCA-gel approach, electrophoresis in one dimension separated RNAs at strand breaks, and then fragments were cleaved at the location of the radical source by iodine-catalyzed scission of phosphorothioate tags (incorporated with the 2′-NH~2~ modifications), before electrophoresis in the second, perpendicular direction ([@bib23]). The resulting patterns gave information on pairs of proximal nucleotides based on their position in the 2D gel, but the method\'s low signal-to-noise necessitated tedious experiments with radical sources separately incorporated at A, C, G, and U residues, each carried out in triplicate, each with at least two different gel electrophoresis times, to achieve a proximity map.10.7554/eLife.07600.003Figure 1.A multidimensional chemical mapping (MCM) pipeline to infer non-coding RNA 3D folds.(**A**) Schematic of mutate-and-map (M^2^) workflow, showing transcription of comprehensive point mutant library and chemical mapping of library with reverse transcription readout ([@bib41]). (**B**) Schematic of Multiplexed •OH (hydroxyl radical) Cleavage Analysis (MOHCA)-seq workflow, showing random incorporation of radical sources, fragmentation, adapter ligations, and analysis by sequencing. (**C**) M^2^ data set for P4--P6 domain of *Tetrahymena* group I ribozyme. (**D**) MOHCA-seq data set (proximity map) for P4--P6. In (**C**) and (**D**), rounded rectangles indicate helix elements with colors matching helices in (**E**--**F**), purple circles indicate hits corresponding to \< 30 Å pairwise distance in the crystal structure, and pink circles indicate hits corresponding to \> 30 Å pairwise distance in the crystal structure. In (**D**), magenta arrows indicate MOHCA-seq hits due to diffusion across the major (top arrow) or minor (bottom arrow) grooves from radical sources located in P5b. (**E--F**) Representation of MOHCA-seq tertiary proximities on M^2^-guided secondary structure (**E**) and on final single Rosetta model (**F**). Purple lines indicate MOHCA-seq hits corresponding to \< 30 Å pairwise distance in the crystal structure. [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} shows stages of MOHCA-seq data analysis in the MAPseeker software package (accessible through the RNA Mapping Database server at <http://rmdb.stanford.edu/tools/>). [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} shows the pseudo-energy potential used for pairwise MOHCA-seq constraints in Rosetta modeling and plots of MOHCA-seq signal vs pairwise distance.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.003](10.7554/eLife.07600.003)10.7554/eLife.07600.004Figure 1---figure supplement 1.MOHCA-seq data analysis.(**A**) Raw counts for a single P4--P6 MOHCA-seq data set. Following paired-end sequencing, the MAPseeker software is used to align the reads to the sequence of the RNA that was probed. (**B**) Closure-based •OH COrrelation Analysis (COHCOA) after 40 iterations on P4--P6 data set. (**C**) Final analyzed P4--P6 proximity map. A filter is applied to remove points with signal-to-noise ratio \< 1, a 2D smoothing algorithm aids visualization of the strongest features, and the data are scaled using the mean of the data. A full description of the analysis is given in the 'Materials and methods'.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.004](10.7554/eLife.07600.004)10.7554/eLife.07600.005Figure 1---figure supplement 2.Pseudo-energy potential used to incorporate MOHCA-seq constraints in Rosetta modeling, and plots of MOHCA-seq signal vs pairwise distance.(**A**) Pseudo-energy potentials for strong (blue) and weak (red) MOHCA-seq constraints. The potential was generated using the smoothstep function (see 'Materials and methods'). (**B**) MOHCA-seq signal vs pairwise distance plot for crystal structures of RNAs listed in [Table 1](#tbl1){ref-type="table"}. (**C**) MOHCA-seq signal vs pairwise distance plot for MCM models of RNAs listed in [Table 1](#tbl1){ref-type="table"} and HoxA9 IRES domain. (**D**) MOHCA-seq signal vs pairwise distance plot for ligand-free MCM models of c-di-GMP, glycine, and AdoCbl riboswitch aptamers shown in [Figures 4C, 5C, 6B](#fig4 fig5 fig6){ref-type="fig"}. Pairwise distances are calculated between 2′-OH of first residue ('radical source location') and C4′ of second residue ('cleavage location'). MOHCA-seq signal is from final COHCOA data sets and ignores pairs of residues separated by fewer than 7 nucleotides due to ambiguities in aligning short reads to the RNA sequence.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.005](10.7554/eLife.07600.005)

MOHCA-seq simplifies and accelerates the readout using techniques developed for RNA-seq (see, e.g., ref. \[[@bib35]\]). To read out strand cleavage sites, the new workflow includes an end-repair step using T4 polynucleotide kinase under conditions that promote its 3′-phosphatase activity ([@bib16]). This reaction permits ligation of a pre-adenylated universal adapter sequence to the 3′-ends of the hydroxyl radical-cleaved RNA fragments, allowing reverse transcription with primers harboring an Illumina adapter and experiment-specific barcodes ([@bib35]). We expected reverse transcription to then stop at the nucleotide tethered to the bulky radical source at its C2′ position, providing a readout of the source position that is more convenient than the MOHCA-gel strand-scission method ([Figure 2A](#fig2){ref-type="fig"}, left). However, we were surprised to find additional stop sites beyond these source attachment positions ([Figure 2A](#fig2){ref-type="fig"}, right), suggesting that reverse transcription could also terminate at sites of additional oxidative damage events, including not only radical-induced strand scission but also other products of ribose or nucleobase oxidation (e.g., 8-oxo-purines and 5-hydroxy-pyrimidines) ([@bib77], [@bib78]; [@bib58]; [@bib56]; [@bib8]; [@bib30]), which are indistinguishable at the cDNA level from stops at tethered radical sources. This high rate of stops would have been difficult to quantify in prior gel and capillary electrophoresis (CE) measurements ([@bib50]; [@bib44]); the rate and proximity of these stops to the radical source were confirmed through both CE and next-generation sequencing tests on a model hairpin RNA with a single radical source attachment position ([Figure 2B--D](#fig2){ref-type="fig"}). The rate of reverse transcription-terminating oxidative damage events exceeds that of strand scission alone by many fold ([Figure 2E](#fig2){ref-type="fig"}). Since these sites of reverse transcription termination marked locations that were also nearby in three dimensions to the radical source, the 5′ and 3′ ends of the resulting cDNAs would still be expected to report pairs of sites that were proximal in the RNA structure, albeit at longer average distances than source-to-cleavage pairs (illustrated in [Figure 2A](#fig2){ref-type="fig"}). Thus, MOHCA-seq enables detection of correlated events previously invisible to MOHCA-gel, and we hypothesized that this significantly larger number of pairwise proximities would permit rapid ncRNA modeling with comparable accuracy to the prior method ([Figure 2A,F--G](#fig2){ref-type="fig"}).10.7554/eLife.07600.006Figure 2.MOHCA-seq detects rich pairwise proximity information in single experiments and is robust to changes in the experimental protocol.(**A**) Schematic illustrating RNA fragments detectable by MOHCA-seq. At left, reverse transcription from a strand scission position (orange bolt) terminates at the radical source (in green); these fragments are also detectable by MOHCA-gel. At right, reverse transcription from strand scission positions can also terminate at additional oxidative damage events (orange circles) caused by the same radical source; these fragments are only detectable by MOHCA-seq. (**B**) Sequence and secondary structure of a proof-of-concept RNA with one radical source attachment site (U13, in green). Cyan rounded rectangles indicate expected MOHCA-seq hits due to RT stops at the radical source after cleavage at the circled residues. (**C**) MOHCA-seq proximity map showing expected hits (cyan rounded rectangles), as well as additional reverse transcription stops occurring 3′ of the radical source position but 5′ of the cleaved and ligated position, due to oxidative damage events 3′ of the radical source that are spatially correlated with the radical source (magenta rounded rectangles). At right, strand scission rates detected by paired-end sequencing (see (**D**)) are shown on a scale from white (low) to black (high) on a visualization-only model of the proof-of-concept RNA. Pairwise hits detectable by MOHCA-gel and MOHCA-seq (as in (**A**), left) are shown as cyan lines; hits detectable by MOHCA-seq only (as in (**A**), right) are shown as magenta lines. (**D**) Quantified strand scission and reverse transcription-terminating modification rates (note difference in scale) in the proof-of-concept RNA from capillary electrophoresis (CE) or paired-end sequencing data (Seq). Blue and orange bars are data for a MOHCA-seq sample with a tethered radical source, and gray bars are data for an identically treated control sample without a radical source. A '\*' indicates a data point that was not included in calculation of the total rate of strand scission due to high background or bleed-through of a fluorescent reference ladder peak. (**E**) Total modification rates for strand scission or reverse transcription stops calculated from CE or sequencing data. (**F**--**G**) MOHCA-seq (**F**) and MOHCA-gel (**G**) proximity maps of P4--P6 from single experiments. MOHCA-gel data were collected previously according to the published method, with 5′-^32^P-labeled P4--P6 RNA ([@bib23]). Rounded rectangles indicate helix elements, purple circles indicate hits corresponding to \< 30 Å pairwise distance in the crystal structure, pink circles indicate hits corresponding to \> 30 Å pairwise distance in the crystal structure, and black circles indicate MOHCA-gel 'spectator hits', which appear due to lack of rigorous background subtraction ([@bib23]; [@bib39]). The pink and purple circles in (**C**) correspond to the hits annotated in [Figure 1D](#fig1){ref-type="fig"}, which shows the average of four data replicates; features that are not circled disappear after averaging. Note distortion of MOHCA-gel compared to MOHCA-seq due to nonlinearity of gel electrophoresis rates with RNA length. (**H**--**K**) MOHCA-seq proximity maps for P4--P6 with alternative 2′-NH~2~-modified nucleotides incorporated during transcription. Modified nucleotide triphosphate included in transcription reaction at molar ratio of 0.5 to unmodified NTP: (**H**) 2′-NH~2~-2′-dATP; (**I**) 2′-NH~2~-2′-dUTP; (**J**) 2′-NH~2~-2′-dGTP; (**K**) 2′-NH~2~-2′-dCTP. All fragmentation reactions were performed for 30 min. All four data sets were collected in one Illumina MiSeq run using a 50-cycle MiSeq Reagent Kit v2. Additional variations of the MOHCA-seq protocol are shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} (variation of radical source incorporation rate) and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} (variation of fragmentation reaction time).**DOI:** [http://dx.doi.org/10.7554/eLife.07600.006](10.7554/eLife.07600.006)10.7554/eLife.07600.007Figure 2---figure supplement 1.Variation of radical source incorporation rate.MOHCA-seq proximity maps for P4--P6. Ratio of concentrations of 2′-NH~2~-2′-dATP to ATP in transcription reaction: (**A**) 0; (**B**) 0.2; (**C**) 0.5 (standard); (**D**) 1.25. All fragmentation reactions were performed for 10 min. Note that 'hits' in (**A**) were weak but are accentuated on the proximity map by scaling (see 'Materials and methods').**DOI:** [http://dx.doi.org/10.7554/eLife.07600.007](10.7554/eLife.07600.007)10.7554/eLife.07600.008Figure 2---figure supplement 2.Variation of fragmentation reaction time.MOHCA-seq proximity maps for P4--P6. Fragmentation reaction time: (**A**) 0 min (no ascorbate added); (**B**) 5 min; (**C**) 12.5 min; (**D**) 30 min. All fragmentations reactions used a 2′-NH~2~-2′-dATP:ATP ratio of 0.5. The P4--P6 construct used for this experiment included flanking hairpins 5′ and 3′ reference hairpins used for standardizing chemical mapping data ([@bib44]) (sequence listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). All four data sets were collected in one Illumina MiSeq run using a 50-cycle MiSeq Reagent Kit v2. Note that 'hits' in (**A**) were weak but are accentuated on the proximity map by scaling (see 'Materials and methods').**DOI:** [http://dx.doi.org/10.7554/eLife.07600.008](10.7554/eLife.07600.008)

After reverse transcription, the MOHCA-seq workflow is completed by ligating a second Illumina adapter to the cDNA library and then determining the 5′ and 3′ ends of each cDNA by paired-end sequencing on a standard Illumina platform ([@bib51]; [@bib61]). MAPseeker software analysis quantifies the data and converts the raw counts into a pairwise proximity map ('Materials and methods' and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Analogous to nuclear Overhauser spectroscopy for NMR structure determination, constraints selected from the analyzed data are then used to guide 3D computational modeling of the ncRNA using the Rosetta software ([@bib18]). Unlike MOHCA-gel, MOHCA-seq does not require specially synthesized nucleotides or 2D gel electrophoresis; the high-throughput sequencing readout improves the signal-to-noise as well as the length windows visible per experiment; and the detection of previously invisible oxidation events enhances the mapping coverage of a single experiment. The protocol\'s throughput is also enhanced by its highly parallel nature, which we leveraged to co-load libraries for multiple RNAs on single sequencing runs ('Materials and methods').

MOHCA-seq tertiary proximity map complements M^2^ secondary structure for Rosetta modeling of P4--P6 {#s2-2}
----------------------------------------------------------------------------------------------------

We first tested the ability of MOHCA-seq to complete our M^2^/Rosetta pipeline by applying it to a well-studied model system with known crystallographic structure, the 158-nucleotide P4--P6 domain of the *Tetrahymena* ribozyme ([@bib17]) (sequence listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). In comparison to prior MOHCA-gel data in which a single experiment yielded a few proximity pairs, raw sequencing counts from a single MOHCA-seq experiment exhibited dozens of pairwise proximity 'hits' throughout the ncRNA ([Figure 2F--G](#fig2){ref-type="fig"}). Additionally, the digital form of MOHCA-seq data enabled computational analysis to resolve further features. Our analysis, called closure-based •OH correlation analysis (COHCOA), is described fully in the 'Materials and methods'. Briefly, COHCOA assumes a two-dimensional background in the raw aligned sequencing data, which arises from two one-dimensional background profiles that are uncorrelated with tethered radical sources: a strand scission profile (leading to horizontal striations) and a reverse transcription-terminating profile (leading to vertical striations) ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Through iterative fitting, COHCOA calculates this two-dimensional background and subtracts it from the raw data and additionally corrects for reverse transcription attenuation. The procedure isolates the MOHCA-seq signal, which arises from oxidative damage that is spatially correlated with tethered radical sources ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). To prevent false positive identification of MOHCA-seq hits due to noise in areas of the proximity map with fewer reads and therefore less signal, we apply a two-dimensional smoothing algorithm to produce the final proximity map for visualization ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}).

A comparison of a single COHCOA-analyzed MOHCA-seq data set to a single MOHCA-gel experiment is shown in [Figure 2F--G](#fig2){ref-type="fig"}, and a final MOHCA-seq data set consisting of four averaged replicates is shown in [Figure 1D](#fig1){ref-type="fig"}. The P4--P6 RNA has five major helical secondary structure elements, P4, P5a, P5b, P5c, and P6, which were originally characterized at high resolution by crystallography and recently confirmed to occur in solution at base-pair resolution by M^2^ experiments ([@bib41]). Indeed, MOHCA-seq proximity hits corresponded to radicals diffusing across the major and minor grooves of each of these helices (visible as two separate branches, arrows in [Figure 1D](#fig1){ref-type="fig"}), confirming the M^2^ secondary structure, albeit at lower resolution (compare [Figure 1C,D](#fig1){ref-type="fig"}). Importantly, nearly two dozen tertiary proximities, including features marking the bend at the J5/5a hinge, the A-minor contact between the A-rich bulge and P4, and the docking of the L5b tetraloop into the J6a/6b receptor, appeared as punctate hits ([Figure 1D--F](#fig1){ref-type="fig"}); only the last of these was clearly observed in M^2^ mapping ([Figure 1C](#fig1){ref-type="fig"}).

To test the robustness of the protocol, we varied several experimental parameters: (1) the 2′-NH~2~-modified nucleotide incorporated during transcription, (2) the radical source incorporation rate, and (3) the fragmentation reaction time. We observed MOHCA-seq features at similar positions (but with variable intensities) whether radical sources were attached at A, C, G, or U ([Figure 2H--K](#fig2){ref-type="fig"}); whether the ratio of 2′-NH~2~-modified nucleotides to standard nucleotides was 1:5, 1:2, or 5:4 ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}); or whether the fragmentation reaction time was 5, 10, or 30 min ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In particular, even after 30 min of radical source activation, the proximity information in the experimental data remains clearly visible without noticeable increase in background, suggesting that the radical source cleaves itself off the RNA in minutes, limiting the reaction. CE of ascorbate-treated end-labeled RNA supported this mechanism of self-limiting the reaction (see also [@bib23]). A few weak signals in the proximity maps that were not predicted by the crystal structure (pink circles, [Figure 1D](#fig1){ref-type="fig"}) may be caused by perturbations of the ncRNA structure by radical source attachment or by conformational dynamics of the RNA or the ∼11 Å benzyl-thiourea linker tethering the radical source to the RNA backbone.

Based on previous MOHCA-gel studies, we expected that our MOHCA-seq data would enable 3D computational modeling of the P4--P6 domain to helical resolution or better without crystallographic information. We used the FARNA with full-atom refinement algorithm in Rosetta ([@bib24]) for modeling, described in detail in the 'Materials and methods'. First, to reduce the computational expense of sampling helices, which primarily adopt A-form conformations, we pre-assembled secondary structure elements in Rosetta. To mimic the lack of high-resolution data for cases of blind RNA structure prediction, we used helices derived from M^2^ and 1D SHAPE mapping for modeling. Second, we performed global modeling in Rosetta in two stages. We generated an initial set of over 10,000 low-resolution models using FARNA in parallel, independent modeling runs; then, we minimized the 1/6 of the models with the lowest Rosetta energy score using full-atom refinement. In both stages, we included MOHCA-seq data to constrain sampling.

To apply the MOHCA-seq data in Rosetta, we generated a list of pairs of residues that were suggested to be proximal by the data by identifying peaks that were (1) distinguishable from the local background signal and (2) not attributable to secondary structure, based on secondary structures inferred by M^2^ ([@bib41]) (purple and pink circles, [Figure 1D](#fig1){ref-type="fig"} and tabulated in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). As in prior work ([@bib23]), we assumed that signals due to dynamic heterogeneity would be weak compared to those due to stable tertiary proximities. Therefore, we used all data, including the few weak features not explained by the crystal structure (pink circles, [Figure 1D](#fig1){ref-type="fig"}), anticipating that the modeling would automatically determine the maximal subset of contacts consistent with each other and with a single structure. Conformational sampling in Rosetta was constrained by applying a smooth pseudo-energy potential ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}) between each pair of residues in the list that favored conformations with the residues between 0 and 30 Å apart and disfavored conformations with the residues more than 30 Å apart. This potential, which was similar to that developed previously for MOHCA-gel analysis, was suggested based on observed correlation of the MOHCA-seq intensity to distances in residue pairs involved in secondary structures ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"} and ref. \[[@bib23]\]) and was validated below.

Finally, we selected a single representative model by clustering the lowest-energy 3% of the refined models using Rosetta. An all-heavy-atom RMSD threshold was chosen to give 1/6 of the clustered models in the most populated cluster, as in prior work ([@bib23]). As in protein structure modeling ([@bib65]), the final single model of this MCM pipeline is the model with the largest number of neighboring models within the RMSD threshold, called the 'cluster center', which is not necessarily the model with the lowest Rosetta energy score. The cluster center represents the best tertiary structure prediction of the MCM pipeline for automated Rosetta modeling guided by experimental data. The RMSD threshold used for clustering represents the intra-cluster RMSD between models in the cluster and is used to calculate an in situ RMSD estimate, representing the precision of modeling (see 'Materials and methods'). The accuracy of the MCM model was calculated as the all-heavy-atom RMSD between the cluster center and the crystal structure, as in our previous study ([@bib23]).

For the P4--P6 benchmark case, we found that the cluster center of the MCM pipeline had an accuracy of 8.6 Å RMSD to the crystal structure ([Figures 1F](#fig1){ref-type="fig"}, [3A](#fig3){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}), which was within the 16.5 Å precision of the modeling estimated from the clustering threshold ([Table 2](#tbl2){ref-type="table"}). This suggests that MCM is capable of defining the global 3D structure of the RNA, without crystallographic information, at near the resolution of a single-nucleotide register shift (6 Å) even when weak MOHCA-seq features not explained by the crystal structure are used to constrain modeling. Performing the same Rosetta modeling protocol without MOHCA-seq pairwise constraints led to a strikingly worse model with 38.3 Å accuracy to the crystal structure ([Figure 3A](#fig3){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}), demonstrating that MOHCA-seq constraints are required for accurate modeling. The 8.6 Å accuracy of the cluster center was better than the previous 13 Å accuracy of modeling guided by MOHCA-gel data, which were collected at substantially greater experimental expense and did not allow base-pair resolution inference of secondary structure, as is now provided by M^2^ analysis ([@bib23]).10.7554/eLife.07600.009Figure 3.MCM achieves 1-nm resolution models of complex RNA folds.(**A**) P4--P6 domain: M^2^/Rosetta model (left), 38.3 Å root-mean-squared-deviation (RMSD); crystal structure (PDB ID 1GID, center left); M^2^/MOHCA-seq/Rosetta (MCM) model (center right), 8.6 Å RMSD. (**B**) *V. cholerae* cyclic-di-GMP riboswitch aptamer: M^2^/Rosetta model (left), 11.3 Å RMSD; crystal structure (PDB ID 3IRW, center left); MCM model (center right), 7.6 Å RMSD. (**C**) *F. nucleatum* double glycine riboswitch ligand-binding domain: M^2^/Rosetta model (left), 30.5 Å RMSD; crystal structure (PDB ID 3P49, center left); MCM model (center right), 7.9 Å RMSD. (**D**) *S. thermophilum* adenosylcobalamin (AdoCbl) riboswitch aptamer: M^2^/Rosetta submission rank 1 of 10 for RNA-puzzle 6 (left), 17.1 Å RMSD; crystal structure (PDB ID 4GXY, center left); MCM model (center right), 11.9 Å RMSD. (**E**) Class I ligase: M^2^/Rosetta model (left), 26.3 Å global RMSD, and 14.0 Å core RMSD; crystal structure (PDB ID 3HHN, center left); MCM model (center right), 14.5 Å global RMSD and 11.1 Å core RMSD. (**F**) *D. iridis* lariat-capping ribozyme: M^2^/Rosetta submission rank 1 of 2 for RNA-puzzle 5 (left), 17.0 Å P2.1/P4--P6 RMSD and 9.6 Å global RMSD; crystal structure (PDB ID 4P8Z, center left); MCM model (center right), 11.2 Å P2.1/P4--P6 RMSD and 8.2 Å global RMSD. In (**A**--**F**), MOHCA-seq proximity maps with annotated helix elements (rounded rectangles) and tertiary hits (purple and pink circles) as in [Figure 1D](#fig1){ref-type="fig"} are shown at right. Full-size proximity maps, including 5′- and 3′-flanking sequences outside the region of interest, are shown in [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}. M^2^ analyses of AdoCbl riboswitch aptamer, class I ligase, and lariat-capping ribozyme are shown in [Figure 3---figure supplements 1, 2, 7](#fig3s1 fig3s2 fig3s7){ref-type="fig"}. [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"} shows comparisons of models generated by different computational methods for RNA-puzzle 6. [Figure 3---figure supplements 5, 6](#fig3s5 fig3s6){ref-type="fig"} show comparisons of additional modeling runs for class I ligase and AdoCbl riboswitch aptamer to crystal structures.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.009](10.7554/eLife.07600.009)10.7554/eLife.07600.010Figure 3---figure supplement 1.M^2^ analysis of the *S. thermophilum* adenosylcobalamin riboswitch aptamer, performed during the sixth RNA-puzzles structure prediction trial.(**A**) M^2^ data set for 1M7 modification across 168 single mutations along the AdoCbl riboswitch aptamer sequence in the presence of 60 µM AdoCbl ligand. Mutants showing poor data quality are marked by red bars. (**B**) Z-score contact map extracted from (**A**). (**C**) Secondary structure prediction and (**D**) bootstrap support matrix using M^2^ data. In (**B**) and (**D**), the crystallographic secondary structure is overlaid as cyan circles.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.010](10.7554/eLife.07600.010)10.7554/eLife.07600.011Figure 3---figure supplement 2.M^2^ analysis of class I ligase.(**A**) M^2^ data set for 1M7 modification across 127 single mutations along the class I ligase sequence. (**B**) Z-score contact map extracted from (**A**). (**C**) Secondary structure prediction and (**D**) bootstrap support matrix using M^2^ data. In (**B**) and (**D**), the crystallographic secondary structure is overlaid as cyan and green circles, with an alternative P3 helix predicted by M^2^ data overlaid as red circles. When SHAPEknots ([@bib31]) was used to predict the pseudoknots in the full sequence, only the P2 pseudoknot was recovered. However, SHAPEknots successfully predicted the P3 helix when the P1 helix was omitted.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.011](10.7554/eLife.07600.011)10.7554/eLife.07600.012Figure 3---figure supplement 3.Full MOHCA-seq proximity maps, including 5′- and 3′-flanking regions.Full COHCOA-analyzed MOHCA-seq proximity maps of (**A**) P4--P6, (**B**) *S. thermophilum* adenosylcobalamin riboswitch aptamer in the presence (left) or absence (right) of 70 µM AdoCbl, (**C**) *D. iridis* lariat-capping ribozyme, (**D**) *V. cholerae* cyclic-di-GMP riboswitch aptamer in the presence (left) or absence (right) of 10 µM c-di-GMP, (**E**) *F. nucleatum* glycine riboswitch ligand-binding domain without leader sequence in the presence (left) or absence (right) of 10 mM glycine, (**F**) class I ligase, (**G**) HoxA9 5′-UTR 957--1132 IRES domain, and (**H**) *F. nucleatum* glycine riboswitch ligand-binding domain with leader sequence ([@bib43]) in the presence (left) or absence (right) of 10 mM glycine. On all maps, the region of interest is enclosed by red lines. All RNAs except for P4--P6 include 5′ and 3′ reference hairpins used for normalizing chemical mapping data from other techniques ([@bib44]) (sequences listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.07600.012](10.7554/eLife.07600.012)10.7554/eLife.07600.013Figure 3---figure supplement 4.Blind models generated for RNA-puzzles can attain 1-nm resolution or better but cannot predict the most accurate models.(**A**) M^2^-derived secondary structure of *S. thermophilus* adenosylcobalamin riboswitch aptamer, generated for the RNA-puzzle 6 challenge ([@bib49]). Bootstrap support values for each helix are shown as percentages. Crystallographic Watson--Crick base pairs missing in the secondary structure are connected by yellow lines, and non-crystallographic Watson--Crick base pairs predicted in the secondary structure are connected by blue lines. (**B**--**G**) Blind 3D models of the *S. thermophilus* adenosylcobalamin riboswitch aptamer generated for the RNA-puzzle 6 challenge. Models were generated using (**B**) M^2^/Rosetta, 12.1 Å all-heavy-atom RMSD to crystal; (**C**) M^2^/Rosetta, 17.1 Å RMSD; (**D**) Vfold, 22.1 Å RMSD; (**E**) MC-Fold and MC-Sym, 23.4 Å RMSD; (**F**) DMD, 24.0 Å RMSD; (**G**) M^2^/Rosetta, 32.8 Å RMSD. Modeling methods were previously described in detail ([@bib49]). For each modeling method, the most accurate submitted model to the crystal structure is shown (**B**, **D**--**F**). The ranks predicted by the modelers of their own submissions ('submission rank') are given below each model. (**H**) Crystal structure of the *S. thermophilus* adenosylcobalamin riboswitch aptamer (PDB ID 4GXY).**DOI:** [http://dx.doi.org/10.7554/eLife.07600.013](10.7554/eLife.07600.013)10.7554/eLife.07600.014Figure 3---figure supplement 5.Comparison of class I ligase crystal structure and knotted and unknotted MCM models.(**A**) Crystal structure of the class I ligase. (**B**) Final MCM model from a cluster with knotted 3′-end (black arrow). (**C**) Final MCM model from a cluster without knotted 3′-end.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.014](10.7554/eLife.07600.014)10.7554/eLife.07600.015Figure 3---figure supplement 6.Comparison between MCM models of the adenosylcobalamin riboswitch aptamer using different initial RNA fragment sets.(**A**) Crystal structure of *S. thermophilum* AdoCbl riboswitch aptamer (PDB ID 4GXY) and MCM models using MOHCA-seq data collected in the presence of (**B**) 70 µM AdoCbl ligand or (**C**) 0 µM AdoCbl ligand. MCM models were generated using three distinct sets of prebuilt RNA fragments prepared during RNA-puzzle modeling (labeled setups 1--3; see 'Materials and methods').**DOI:** [http://dx.doi.org/10.7554/eLife.07600.015](10.7554/eLife.07600.015)10.7554/eLife.07600.016Figure 3---figure supplement 7.M^2^ analysis of the GIR1 lariat-capping ribozyme, performed during the fifth RNA-puzzles structure prediction trial.(**A**) M^2^ data set for 1M7 modification across 188 single mutations along the GIR1 ribozyme sequence. Mutants showing poor data quality are marked by red bars. (**B**) Z-score contact map extracted from (**A**). (**C**) Secondary structure prediction and (**D**) bootstrap support matrix using M^2^ data. In (**B**) and (**D**), the crystallographic secondary structure is overlaid as cyan circles.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.016](10.7554/eLife.07600.016)10.7554/eLife.07600.017Table 1.Benchmark of MCM on RNAs with crystal structures**DOI:** [http://dx.doi.org/10.7554/eLife.07600.017](10.7554/eLife.07600.017)RNALengthM^2^/Rosetta (no MOHCA, control)MCMRMSD to crystal (Å) (accuracy)p-value[§](#tblfn4){ref-type="table-fn"}RMSD to crystal (Å) (accuracy)p-value[§](#tblfn4){ref-type="table-fn"}*Tetrahymena* ribozyme P4--P6 domain15838.3\>0.98.6\<1.0 × 10^−16^V. cholerae cyclic-di-GMP riboswitch aptamer, ligand-bound[\*](#tblfn1){ref-type="table-fn"}8911.32.6 × 10^−3^7.66.3 × 10^−7^F. nucleatum double glycine riboswitch ligand-binding domain, ligand-bound[\*](#tblfn1){ref-type="table-fn"}15930.5\>0.97.9\<1.0 × 10^−16^S. thermophilum adenosylcobalamin riboswitch aptamer, ligand-bound[\*](#tblfn1){ref-type="table-fn"}16817.1[†](#tblfn2){ref-type="table-fn"}5.3 × 10^−7^11.94.0 × 10^−15^Class I ligase12726.3\>0.914.56.8 × 10^−5^Class I ligase, core domain[‡](#tblfn3){ref-type="table-fn"}8714.00.1311.13.1 × 10^−3^D. iridis lariat-capping ribozyme1889.6[†](#tblfn2){ref-type="table-fn"}\<1.0 × 10^−16^8.2\<1.0 × 10^−16^*D. iridis* lariat-capping ribozyme, MCM refined regions[‡](#tblfn3){ref-type="table-fn"}6917.0[†](#tblfn2){ref-type="table-fn"}n.a.[§](#tblfn4){ref-type="table-fn"}11.2n.a.[§](#tblfn4){ref-type="table-fn"}[^1][^2][^3][^4][^5]10.7554/eLife.07600.018Table 2.Precision and constraint statistics of MCM modeling, including conformationally heterogeneous states**DOI:** [http://dx.doi.org/10.7554/eLife.07600.018](10.7554/eLife.07600.018)RNALengthNumber of modelsSize of largest clusterRMSD to crystal, cluster center (Å) (accuracy)In situ RMSD estimate (Å) (precision)Total constraintsPercent strong constraints satisfied,[\*](#tblfn5){ref-type="table-fn"} cluster centerPercent strong constraints satisfied, crystalPercent weak constraints satisfied, cluster centerPercent weak constraints satisfied, crystal*Tetrahymena* ribozyme P4--P6 domain15861,115488.616.53565.469.255.644.4*V. cholerae* cyclic-di-GMP riboswitch aptamer, bound8915,632107.66.819100.0100.0100.075.0*V. cholerae* cyclic-di-GMP riboswitch aptamer, unbound[†](#tblfn6){ref-type="table-fn"}8926,4215(26.0)[‡](#tblfn7){ref-type="table-fn"}9.814100.083.375.037.5*F. nucleatum* double glycine riboswitch ligand-binding domain, bound15916,506147.910.03195.8100.057.142.9*F. nucleatum* double glycine riboswitch ligand-binding domain, unbound[†](#tblfn6){ref-type="table-fn"}15915,77112(25.4)[‡](#tblfn7){ref-type="table-fn"}26.712N/A[§](#tblfn8){ref-type="table-fn"}N/A[§](#tblfn8){ref-type="table-fn"}58.383.3*F. nucleatum* double glycine riboswitch ligand-binding domain with leader, bound16723,1531911.810.64989.584.283.383.3*F. nucleatum* double glycine riboswitch ligand-binding domain with leader, unbound[†](#tblfn6){ref-type="table-fn"}16718,09615(15.6)[‡](#tblfn7){ref-type="table-fn"}14.73477.833.364.068.0*S. thermophilum* adenosylcobalamin riboswitch aptamer, bound[\#](#tblfn9){ref-type="table-fn"}16814,2191211.913.93884.076.084.669.2*S. thermophilum* adenosylcobalamin riboswitch aptamer, unbound[†](#tblfn6){ref-type="table-fn"},[\#](#tblfn9){ref-type="table-fn"}16811,98010(17.3)[‡](#tblfn7){ref-type="table-fn"}19.73383.394.473.373.3Class I ligase (unknotted)12717,881714.511.62486.753.322.277.8Class I ligase (unknotted), core domain[¶](#tblfn10){ref-type="table-fn"}8717,881711.112.01891.758.333.350.0Class I ligase (knotted)12717,8811416.111.62486.753.355.677.8*D. iridis* lariat capping ribozyme18819,741168.25.73290.070.054.554.5*D. iridis* lariat capping ribozyme, RNA-puzzles submission model \#1 (2012)188----9.6----60.070.059.154.5*D. iridis* lariat capping ribozyme, MCM refined regions[¶](#tblfn10){ref-type="table-fn"}6919,7411611.210.53287.562.546.238.5*D. iridis* lariat capping ribozyme, RNA-puzzles submission model \#1 (2012), MCM refined regions[\#](#tblfn9){ref-type="table-fn"}69----17.0----50.062.546.238.5HoxA9 5′-UTR 957--1132 domain, pseudoknot17615,58012--19.52041.7--50.0--HoxA9 5′-UTR 957--1132 domain, no pseudoknot17611,2348--19.82133.3--22.2--[^6][^7][^8][^9][^10][^11][^12]

The cluster center MCM model correctly inferred the global 3D structure of the P4--P6 domain, including the compaction of the P5c helix and A-rich bulge toward P4 and the clothespin-like bend allowing proximity of the L5b tetraloop and the J6a/6b receptor. Nevertheless, we found that the resolution was not sufficient to recapitulate nucleotide-level details, such as the base stacking and base--triple interactions in the tetraloop/tetraloop receptor contact. If the P4--P6 domain were a blind prediction case, the MOHCA-seq data and MCM model would have marked these regions as sites for further biochemical investigation, but accurate recovery of the detailed interactions would still require advances in computational methods being developed for refining conformations of motifs to high resolution ([@bib68]). Additionally, not all MOHCA-seq constraints were satisfied by either our cluster center MCM model or the crystal structure, an observation discussed further below.

MCM allows rapid modeling of diverse ncRNAs, including blind prediction challenges {#s2-3}
----------------------------------------------------------------------------------

Our initial studies on the P4--P6 RNA suggested that the MCM pipeline, consisting of M^2^ and MOHCA-seq experiments followed by Rosetta modeling, could be a generally applicable approach for determining global structures of ncRNAs. To further test this hypothesis, we benchmarked MCM on several additional ncRNAs with known structures but distinct functions: the 89-nucleotide *Vibrio cholerae* cyclic-di-GMP (c-di-GMP) riboswitch aptamer bound to its ligand at 10 µM c-di-GMP ([@bib67]), the 159-nucleotide ligand-binding domain of the *Fusobacterium nucleatum* double glycine riboswitch (consisting of two tandem glycine aptamers) bound to two glycines at 10 mM glycine ([@bib15]), the 168-nucleotide *Symbiobacterium thermophilum* adenosylcobalamin (AdoCbl) riboswitch aptamer bound to its ligand at 70 µM AdoCbl ([@bib55]), and the 127-nucleotide class I ligase including substrate obtained from in vitro selection ([@bib26]; [@bib63]) (sequences listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). For the glycine riboswitch ligand-binding domain, the AdoCbl riboswitch aptamer, and the class I ligase, the secondary structures were first defined at nucleotide resolution by high-throughput M^2^ analysis; data from this previously established approach were collected in prior work ([@bib41]) or are shown in [Figure 3---figure supplements 1, 2](#fig3s1 fig3s2){ref-type="fig"}. MOHCA-seq data and Rosetta modeling completed the MCM pipeline ([Figure 3B--E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 3B--E](#fig3s3){ref-type="fig"}). As described above for the P4--P6 RNA and in prior work on 3D ncRNA modeling, precision estimates were possible in situ without knowledge of the actual structure by assessing convergence of independent modeling runs ('Materials and methods'); all cases suggested 1-nm resolution had been achieved ([Table 2](#tbl2){ref-type="table"}). Indeed, this resolution was attained by MCM in all cases: 7.6 Å for the c-di-GMP riboswitch aptamer; 7.9 Å for the glycine riboswitch ligand-binding domain; 11.9 Å for the AdoCbl riboswitch aptamer (compare to RNA-puzzle 6 models, [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}); and 11.1 Å (ribozyme) and 14.5 Å (ribozyme including substrate) for the class I ligase ([@bib63]) ([Figure 3B--E](#fig3){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}; clusters with knots were not accepted, see [Figure 3---figure supplement 5](#fig3s5){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). The lack of correlation between the fraction of satisfied MOHCA-seq pairwise constraints and the accuracy of the models ([Table 2](#tbl2){ref-type="table"}) suggests that unsatisfied constraints are due to conformational fluctuations in the RNA or radical-source linkers around the dominant global structures of these molecules, rather than systematic structural shifts or incomplete computational sampling. The generally consistent accuracy of these predictions supports our hypothesis that highly sampled computational modeling is able to filter out such inconsistent constraints, as has been observed in prior macromolecule modeling based on pairwise information ([@bib13]; [@bib23]; [@bib69]). Further supporting the assumptions of modeling, including the form of the pseudo-energy function, the relationship of MOHCA-seq signal intensities to pairwise distances seen in crystal structures was recovered by MCM models ([Figure 1---figure supplement 2B,C](#fig1s2){ref-type="fig"}). Again, we tested the necessity of MOHCA-seq data for completing the MCM pipeline by performing identical modeling of all ncRNA domains without MOHCA-seq constraints (M^2^/Rosetta modeling). Just as for the P4--P6 domain, these runs produced dramatically less accurate models, as can be visually assessed ([Figure 3](#fig3){ref-type="fig"}) and quantitated by both RMSD to the crystal structure and statistical significance ([@bib32]) ([Table 1](#tbl1){ref-type="table"}).

In addition to generating accurate models, the full MCM pipeline enabled selection of *single* confident 1-nm resolution tertiary structures in each of the above cases, an achievement highlighted by the AdoCbl riboswitch aptamer test case. For this RNA-puzzle target, we previously collected and disseminated M^2^ data ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) that correctly discriminated between literature models of this ncRNA\'s secondary structure ([@bib55]). However, these data did not disambiguate between a range of 3D structures, and our ten submitted models gave RMSDs from 12.1 Å to 32.8 Å to the subsequently released riboswitch aptamer crystal structure ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). With the developments in this study, we suspected that MOHCA-seq data would complement our M^2^/Rosetta method and permit confident selection and submission of a single model. Indeed, the full MCM pipeline resolved tertiary contacts between the peripheral and core regions of the ncRNA ([Figure 3D](#fig3){ref-type="fig"}), and automated modeling converged to a structure defined with 13.9 Å resolution (in situ precision estimate), which achieved 11.9 Å RMSD to the crystal structure ([Figure 3D](#fig3){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"}, [Figure 3---figure supplement 6](#fig3s6){ref-type="fig"}, and 'Materials and methods'), comparable to the accuracy of our best RNA-puzzle submission and clearly defining the global structure to helix resolution.

As a rigorous test, we applied MCM to model another RNA-puzzle before the release of its crystal structure, a 188-nucleotide lariat-capping ribozyme from *Didymium iridis*. As part of this blind challenge, we previously collected and shared M^2^ data ([Figure 3---figure supplement 7](#fig3s7){ref-type="fig"}) that supported literature models of the ncRNA\'s secondary structure and suggested two additional tertiary contacts creating a 'ring' around the ribozyme. Nevertheless, during the RNA-puzzle time window in the summer of 2012, modeling from M^2^ alone was uncertain, particularly in the long, kissing helical stacks P2.1 and P4--P6, which had no homologies to any experimentally solved structure (blue and green regions, [Figure 3F](#fig3){ref-type="fig"}). After developing MOHCA-seq but before the release of the lariat-capping ribozyme crystal structure, we completed the MCM pipeline by acquiring MOHCA-seq data for the ncRNA ([Figure 3F](#fig3){ref-type="fig"}), and the resulting map highlighted potential errors in these extended peripheral regions. We then blindly refined the peripheral regions based on the full MCM data ([Figure 3F](#fig3){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}), and the subsequent release of the ribozyme crystal structure ([@bib48]) confirmed that their accuracy significantly improved, from an original RMSD of 17.0 Å (original RNA-puzzle submission, M^2^/Rosetta) to a final RMSD of 11.2 Å (full MCM, i.e., M^2^/MOHCA-seq/Rosetta). The global accuracy of the models also improved, with a range of RMSDs over the full ribozyme from 7.6 to 8.9 Å, compared to our original submission, which turned out to have an overall RMSD accuracy of 9.6 Å. Taken together, these results rigorously demonstrated the ability of the full MCM pipeline to detect errors and to consistently and blindly refine ncRNA structures to 1-nm resolution or better throughout complex structures.

Direct nucleotide-resolution observation of preformed riboswitch aptamer tertiary structure using MCM {#s2-4}
-----------------------------------------------------------------------------------------------------

Riboswitches form a major class of ncRNAs, and understanding their structures in the absence of ligands is critical for dissecting mechanisms of ligand capture and modulation of gene expression. While crystal structures and solution scattering of a few ligand-free riboswitch aptamers have suggested the possibility of extensive preformed tertiary structure in special cases ([@bib62]; [@bib6]; [@bib75]), whether these structures are generally sampled in solution in the absence of ligand has remained poorly understood due to the lack of an unbiased, high-throughput solution structural technique. We tested if MCM could resolve previously missing information on ligand-free states of the three riboswitch aptamers that were characterized above in their ligand-bound forms. Because the computational modeling of heterogeneous conformational ensembles from experimental data is an open problem ([@bib10]; [@bib60]; [@bib64]), our primary conclusions below are based on the M^2^ and MOHCA-seq data themselves, with Rosetta modeling carried out for initial visualization only (see 'Materials and methods').

We first applied MCM to the c-di-GMP riboswitch aptamer without its ligand, which had been previously studied with state-of-the-art small-angle X-ray scattering, single-molecule FRET, and kinetic analysis ([@bib45]; [@bib75]). These prior studies revealed an extended conformation of this ncRNA transiently interconverting with a 'docked' conformation that shares at least one tertiary contact with the ligand-bound docked state (P1b/P2 tetraloop/receptor). MCM rapidly recovered this picture and provided additional information. In terms of secondary structure, M^2^ measurements gave P1a, P1b, and P2 helices in both ligand-free and ligand-bound states, up to possible rearrangements in edge base pairs ([@bib41]), and MOHCA-seq additionally confirmed all 3 helices in both states ([Figure 4A](#fig4){ref-type="fig"}). In terms of tertiary structure, unambiguous proximities between several segments of P1b and P2 that were detected in the ligand-bound state ([Figure 4A](#fig4){ref-type="fig"}, left) were also observed at the same locations, albeit weakly, in the ligand-free state ([Figure 4A](#fig4){ref-type="fig"}, right). To test that these tertiary features were not due to noise or experimental artifacts in MOHCA-seq experiments or data processing, we confirmed that they disappeared in solution conditions without Mg^2+^ ([Figure 4B](#fig4){ref-type="fig"}). The matching 'fingerprints' of cross-helix tertiary features in ligand-free and ligand-bound MOHCA-seq maps provided evidence that the ligand-free riboswitch aptamer samples the same tertiary conformation as the ligand-bound docked state at nanometer resolution, including and going beyond the known tetraloop/receptor contact.10.7554/eLife.07600.019Figure 4.The *V. cholerae* cyclic-di-GMP riboswitch aptamer exhibits Mg^2+^-dependent preformed tertiary structure in its ligand-free state.(**A**) Proximity maps of c-di-GMP riboswitch aptamer in 10 µM (left) or 0 µM (right) c-di-GMP, folded in 10 mM Mg^2+^, with annotated helix elements (rounded rectangles) and tertiary hits (purple and pink circles). (**B**) Proximity maps of c-di-GMP riboswitch aptamer in 10 µM (left) or 0 µM (right) c-di-GMP, folded in 0 mM Mg^2+^, showing absence of tertiary proximities that are present for the aptamer folded in 10 mM Mg^2+^. (**C**) Five MCM models with lowest Rosetta energy of c-di-GMP riboswitch aptamer give an initial visualization of ligand-free ensemble (left); modeling included pseudo-energy constraints from 0 µM c-di-GMP and 10 mM Mg^2+^ proximity map. The crystal structure is shown at right for comparison.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.019](10.7554/eLife.07600.019)

To visualize the ensemble, we performed Rosetta modeling as above and discovered that the conformational heterogeneity of the top cluster was significantly larger than clustering of ligand-bound states above (9.8 Å vs 6.8 Å, respectively; [Table 2](#tbl2){ref-type="table"}), suggesting that a significant fraction of the visible variance ([Figure 4C](#fig4){ref-type="fig"}) arises from actual RNA conformational dynamics rather than from modeling uncertainties. As in NMR studies of dynamic molecules, we therefore inspected an ensemble of models with the lowest Rosetta energy score instead of focusing on the cluster center; the resulting ensemble was used for initial visualization only ([@bib1]; [@bib12]; [@bib60]). Four of the five lowest energy models were primarily extended and without tertiary contacts, with one showing a more compact state similar to the one stabilized by ligand. The MOHCA-seq data are thus consistent with a picture of the ligand-free state of the c-di-GMP riboswitch aptamer primarily adopting extended conformations but also interconverting to more compact ones ([Figure 4C](#fig4){ref-type="fig"}).

MCM analysis of riboswitch aptamers for glycine and adenosylcobalamin gave surprisingly similar results to our investigation of the c-di-GMP riboswitch aptamer. The glycine riboswitch ligand-binding domain consists of two glycine-binding aptamers connected by a linker; the formation of cross-aptamer contacts upon ligand binding could explain the cooperativity of glycine binding between the aptamers ([@bib27]; [@bib43]; [@bib28]; [@bib59]), but has not been directly visualized. In terms of secondary structure, previous M^2^ data indicated that three major helical elements P1, P2, and P3 were formed by each of the two aptamers, both with and without glycine ([@bib41]); MOHCA-seq data gave additional support for this six-helix secondary structure being preformed without ligand ([Figure 5A](#fig5){ref-type="fig"}). Strikingly, tertiary proximity hits observed both within and across the two aptamers in the glycine-bound state were retained, though weakened, in the absence of glycine ([Figure 5A](#fig5){ref-type="fig"} and [Figure 3---figure supplement 3H](#fig3s3){ref-type="fig"}). Analogous to our control experiments for the c-di-GMP riboswitch aptamer, these tertiary proximities were not detectable in conditions without Mg^2+^ ([Figure 5B](#fig5){ref-type="fig"}). Completing the MCM pipeline, Rosetta modeling of the ligand-free state with M^2^/MOHCA-seq constraints gave a structural ensemble with an approximately similar global structure but substantially more conformational variance than the ligand-bound state ([Figure 5C](#fig5){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). These MCM models provide a framework for further dissection of the ligand-free state of the glycine riboswitch aptamers through mutation and MCM. As an example, we discovered that the preformed tertiary proximities detected by MCM in the ligand-free riboswitch aptamer depend critically on at least one junction element, a leader sequence that was missed in crystallographic studies but later shown to stabilize a K-turn linker between the aptamers ([Figure 5D,E](#fig5){ref-type="fig"}) ([@bib43]; [@bib28]; [@bib59]).10.7554/eLife.07600.020Figure 5.The *F. nucleatum* double glycine riboswitch ligand-binding domain retains preformed tertiary structure in its ligand-free state, with a requirement of a leader sequence.(**A**) Proximity maps of glycine riboswitch ligand-binding domain in 10 mM (left) or 0 mM (right) glycine, folded in 10 mM Mg^2+^, with annotated helix elements (rounded rectangles) and tertiary hits (purple and pink circles). A black box encloses each glycine-binding aptamer. (**B**) Proximity maps of glycine riboswitch ligand-binding domain in 10 mM (left) or 0 mM (right) glycine, folded in 0 mM Mg^2+^, showing absence of tertiary proximities both within and between aptamers that are present for the ligand-binding domain folded in 10 mM Mg^2+^. (**C**) Five MCM models with lowest Rosetta energy of glycine riboswitch ligand-binding domain give an initial visualization of ligand-free ensemble (left); modeling included pseudo-energy constraints from 0 mM glycine and 10 mM Mg^2+^ proximity map. The crystal structure, with kink-turn linker grafted from PDB ID 3CC2 ([@bib43]), is shown at right for comparison. (**D**) Proximity maps of glycine riboswitch ligand-binding domain without leader sequence in 10 mM (left) or 0 mM (right) glycine, folded in 10 mM Mg^2+^, showing absence of tertiary proximities between aptamers even in presence of Mg^2+^. (**E**) Five MCM models with lowest Rosetta energy of glycine riboswitch ligand-binding domain without leader sequence give an initial visualization of ligand-free ensemble (left); modeling included pseudo-energy constraints from 0 mM glycine and 10 mM Mg^2+^ proximity map.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.020](10.7554/eLife.07600.020)

Compared to the riboswitch aptamers above, much less was previously known about the AdoCbl riboswitch aptamer. Indeed, long-standing controversies in modeling this ncRNA raised the possibility of differences in both secondary and tertiary structure in states with and without ligand ([@bib57]; [@bib52]; [@bib72]; [@bib53]; [@bib9]; [@bib49]). Nevertheless, MCM revealed striking similarities between the states, most clearly visible in MOHCA-seq data ([Figure 6A](#fig6){ref-type="fig"}). In terms of secondary structure, features for six major helical stacks appeared identical with and without ligand. In terms of tertiary structure, the data without ligand showed reduction but not complete loss of strong tertiary proximities between helices that enclose the ligand-binding site ([Figure 6A](#fig6){ref-type="fig"}). As above, Rosetta modeling produced an initial visualization of a loose structural ensemble that samples, but does not stably remain in, the ligand-bound structure within the nanometer resolution of the MOHCA-seq method ([Figure 6B](#fig6){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). Again, by rapidly resolving secondary and tertiary structure, this MCM analysis sets a foundation for further dissection of this RNA\'s ligand-free globule. As a first example, we found that the sole long-range tertiary interaction in the AdoCbl-binding site (an A-minor contact between J11-10 and helix P6) was necessary for ligand binding but not the global tertiary proximities measured by MOHCA-seq ([Figure 6C,D](#fig6){ref-type="fig"}). Like the data for the glycine riboswitch aptamers above, these data further suggest that the ligand-free proximities in the AdoCbl riboswitch aptamer arise not from direct tertiary contacts but from conformational preferences encoded in the riboswitch aptamer junctions.10.7554/eLife.07600.021Figure 6.The *S. thermophilus* adenosylcobalamin riboswitch aptamer retains preformed tertiary structure without binding ligand.(**A**) Proximity maps of AdoCbl riboswitch aptamer in 70 µM (left) or 0 µM (right) AdoCbl with annotated helix elements (rounded rectangles) and tertiary hits (purple and pink circles). Red arrows indicate regions of proximity between J11-10 and helix P6 in the crystal structure. (**B**) Three MCM models with lowest Rosetta energy of AdoCbl riboswitch aptamer give an initial visualization of ligand-free ensemble (left); modeling included pseudo-energy constraints from 0 µM AdoCbl proximity map. The crystal structure is shown at right for comparison. (**C**--**D**) Mutation of A124 and A125 to U disrupts ligand-binding but not preformed tertiary structure. (**C**) Proximity maps of A124U/A125U mutant AdoCbl riboswitch aptamer in 70 µM (left) or 0 µM (right) AdoCbl, showing retention of tertiary proximity hits similar to the wild-type aptamer in 0 µM AdoCbl. (**D**) 1D chemical mapping reactivities of wild-type and A124U/A125U ('Mut') AdoCbl riboswitch aptamer. Green arrows in DMS reactivity lanes indicate locations of reduced reactivity in the presence of ligand in the wild type only. Residues 124 and 125 are unreactive to DMS in the A124U/A125U mutant because DMS does not modify U residues. Blue arrow in CMCT reactivity lanes indicates lack of protection of U124 and U125 in the mutant in the presence of ligand. Magenta arrows in SHAPE reactivity indicate locations of reduced/altered reactivity in the presence of ligand in the wild type but not in the mutant. All ligand-dependent protections are located in or near the AdoCbl-binding site in the riboswitch aptamer ([@bib55]).**DOI:** [http://dx.doi.org/10.7554/eLife.07600.021](10.7554/eLife.07600.021)

Solution structure determination of a recently discovered ncRNA {#s2-5}
---------------------------------------------------------------

The discovery in recent months of cellular internal ribosome entry site (IRES) elements in the 5′-UTRs of the Hox mRNAs has suggested new roles of structured ncRNAs in mammalian development ([@bib76]). To further demonstrate the potential of MCM 3D modeling for investigating systems of timely biological interest, we probed a 176-nt structured domain of the HoxA9 5′-UTR that was shown to be critical for IRES activity. The secondary structure of the domain was determined by M^2^, along with in vivo mutation-rescue experiments that confirmed key helix elements ([Figure 7A](#fig7){ref-type="fig"}) ([@bib76]). We collected MOHCA-seq data that corroborated the secondary structure described previously and provided independent support for a pseudoknot (pk3-4) connecting two arms of a four-way junction, a common feature of viral IRESes that has not been demonstrated for cellular IRESes ([Figure 7A,B](#fig7){ref-type="fig"}). We completed the MCM pipeline to computationally model the domain\'s global 3D structure, revealing a core four-way junction aligned by the pseudoknot, defined at an estimated resolution of 19.5 Å, similar to the loose ensembles seen in our MCM models of ligand-free riboswitch aptamers ([Figure 7C](#fig7){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). Supporting this global structure and estimated resolution, modeling that used an alternative pk3-4-free secondary structure gave a final conformation within 19.5 Å RMSD of the cluster center with pseudoknot ([Figure 7D](#fig7){ref-type="fig"}; alternative secondary structure from Extended Data [Figure 6C](#fig6){ref-type="fig"} in ref. \[[@bib76]\]). Given the conformational heterogeneity of this 176-nucleotide ncRNA in the absence of partners, MCM appears to be the only front-line technique able to resolve this domain\'s global structure in isolation, which we propose to be a recognition site for the mammalian 80S ribosome. These models provide fiducial landmarks to seek in upcoming cryo-electron microscopy studies of the HoxA9 IRES in the presence of the ribosome and other macromolecular partners (PDB-formatted models are available online in [Source code 1](#SD3-data){ref-type="supplementary-material"}).10.7554/eLife.07600.022Figure 7.MCM analysis of a recently discovered human cellular mRNA IRES domain.(**A**) M^2^-derived secondary structure model of HoxA9 5′-UTR 957--1132 internal ribosome entry site (IRES) domain. (**B**) MOHCA-seq proximity map of HoxA9 IRES domain, with evidence for secondary structure elements and pseudoknot predicted by M^2^ and validated by mutate-and-rescue experiments ([@bib76]) (rounded rectangles). Tertiary hits are indicated by purple circles. (**C**) MCM model of HoxA9 IRES domain with explicit pseudoknot pk3-4. (**D**) MCM model of HoxA9 IRES domain without explicit pseudoknot pk3-4. In (**C**--**D**), cluster center (opaque) and four additional models (semi-transparent) from the top cluster are shown. Magenta lines connect base pairs of pk3-4 in each cluster center model. Top cluster models for both modeling setups are available in [Source code 1](#SD3-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07600.022](10.7554/eLife.07600.022)

Discussion {#s3}
==========

Despite rapid advances in secondary structure inference from chemical mapping and computational modeling, inference of three-dimensional ncRNA structures has been bottlenecked by an inability to experimentally determine how a molecule\'s helices and non-canonical motifs assemble into complex global structures. The MCM methods described herein leverage tabletop sequencing platforms and commercially available reagents to provide a straightforward route to such proximity information. In the MCM pipeline, both M^2^ and MOHCA-seq experiments provide critical data to guide Rosetta computational modeling. M^2^ defines the secondary structure but cannot generally constrain helical elements into accurate tertiary structures, while MOHCA-seq provides tertiary proximities but does not reveal secondary structure as finely as M^2^. Analogous to how pipelining Heteronuclear Single Quantum Coherence (HSQC) spectroscopy, NOE measurements, and computational modeling allows routine NMR-based structure determination of small RNA motifs, we have shown that the M^2^/MOHCA-seq/Rosetta pipeline achieves models for larger ncRNA structures, including blind test cases, with accuracies of 1 nm.

Beyond resolving the global structures of well-structured ncRNA states, MCM provides global structural frameworks to guide structure-function analyses of ncRNAs that adopt multiple conformations. MCM data corroborate and refine models of ligand-independent tertiary structure in a c-di-GMP riboswitch aptamer and reveal similarly preformed tertiary structure in glycine and AdoCbl riboswitch aptamers. Mutational analysis confirms the importance of junctions in defining these ligand-free global tertiary preferences. Such preformed structure may be needed for rapid kinetic capture of cognate ligands in vivo. We propose that current exceptions to this rule, such as the thiamine pyrophosphate riboswitch aptamer ([@bib2]), may also form such 'loose tertiary globules' when probed with flanking elements or macromolecule partners that have not yet been identified, as they were for the glycine riboswitch aptamers. As such new elements are identified, MCM will provide a uniquely rapid method to test their effects on riboswitch aptamer structure both with and without ligand.

As an example of rapid modeling of a complex and biologically important ncRNA, MCM has revealed a global structure for a HoxA9 IRES domain almost immediately after its discovery as a regulator of vertebrate body plan. The structure is less well-defined than the other ncRNAs but exhibits a pseudoknot that is a common feature of viral IRESes. Other macromolecules that recognize this IRES domain, including the 80S ribosome, may further stabilize or remodel this ncRNA\'s 'naked' tertiary structure, and MCM will provide a rapid approach to characterizing such structural effects.

In addition to establishing MCM as a routine approach to achieve medium-resolution structures of ncRNA domains, our results suggest both experimental and computational extensions to expand the technology. Cell-permeable nucleotide analogs or chemical modifiers may enable in vivo 3D structure determination. The experimental cost of MCM grows quadratically with the length of the transcript, limiting current analysis to domains of hundreds of nucleotides; however, \>1000-nt transcripts may become feasible as sequencing costs continue to decrease and if new strategies to bypass reverse transcription stops are implemented ([@bib66]). A fraction of observed MOHCA-seq constraints do not reflect structures solved by crystallography; quantitative relationships correlating MCM data to structural features should further improve modeling accuracy and enable error estimation and cross-validation by leaving out constraints during modeling, analogous to continuing advances in NMR methods. Additionally, stabilization of alternative states by mutation, coupled with ensemble-based analyses, may allow for more detailed dissection of multiple ncRNA tertiary conformations and their functions. Finally, improving computational methods may enable refinement of 1-nm resolution models to higher resolution, possibly near-atomic accuracy; this computational problem appears significantly more amenable than completely de novo 3D modeling. We hope that the public availability of our MCM data, their acquisition in ongoing RNA-puzzles, and the detailed methodological descriptions in this report will help accelerate these developments and more comprehensively illuminate the complex structures underlying ncRNA biology.

Materials and methods {#s4}
=====================

Mutate-and-map (M^2^) {#s4-1}
---------------------

High-confidence secondary structures derived from M^2^ experiments were used as inputs to computational modeling. We previously collected M^2^ data on the AdoCbl riboswitch aptamer in the presence of 60 µM AdoCbl and separately performed M^2^ on the class I ligase using experimental methods and data analysis that have been described in detail ([@bib41]; [@bib21]). The M^2^ data are available on the RNA Mapping Database (RMDB) with accession IDs RNAPZ6_1M7_0002 (AdoCbl riboswitch aptamer) and CL1LIG_1M7_0001 (class I ligase). The solution conditions were 50 mM Na-HEPES, pH 8.0, and 10 mM MgCl~2~, as used previously and for MOHCA-seq experiments below. [Figure 3---figure supplements 1, 2, 7](#fig3s1 fig3s2 fig3s7){ref-type="fig"} present previously unpublished M^2^ data and analysis for the AdoCbl riboswitch aptamer, class I ligase, and lariat-capping ribozyme, respectively.

MOHCA-seq measurements {#s4-2}
----------------------

### RNA preparation {#s4-2-1}

Double-stranded DNA templates for the RNAs of interest were constructed using PCR assembly with primers purchased from IDT (Integrated DNA Technologies, San Diego, CA) ([@bib41]). RNAs were transcribed at 37°C for 3 hr in 320 µl reactions containing 32 pmol of dsDNA template, 100 mM Tris--HCl, pH 8.1, 200 mM MgCl~2~, 3.5 mM spermidine, 0.1% Triton X-100, 40 mM DTT, 4% PEG 8000, 20 U T7 RNA Polymerase (New England Biolabs \[NEB\], Ipswich, MA), 1 mM NTPs, and 0.5 mM 2′-NH~2~-2′-deoxy-ATP (TriLink BioTechnologies, San Diego, CA). The yield of transcription was 1--1.5 nmol after purification using RNA Clean & Concentrator columns (Zymo Research, Irvine, CA). Purified RNA was then ethanol precipitated to concentrate it for 5′-end labeling using a 5′ EndTag kit and fluorescein maleimide (Vector Labs, Burlingame, CA) to enable gel visualization in subsequent steps; the RNA was then purified again using RNA Clean & Concentrator columns. The hydroxyl radical source, isothiocyanobenzyl-EDTA chelating Fe(III) (ITCB-Fe(III)•EDTA) (Dojindo Molecular Technologies, Inc., Santa Clara, CA), was covalently attached to the 2′-NH~2~ groups on the RNA backbone using a two-step process. First, to couple ITCB-EDTA to the RNA, 0.5 mg ITCB-EDTA was dissolved in 5.7 µl 0.4 M KPO~4~, pH 8.5 for a concentration of 200 mM, then mixed with 15 µl of RNA and 15 µl 0.8 M KPO~4~, pH 8.5. The coupling reactions were incubated at 37°C for 12--16 hr. Then, 1/3 vol of 200 mM FeCl~3~ was added and the coupling reactions were incubated at room temperature for 15 min, after which 10 µl 500 mM Na-EDTA, pH 8.0 was added to chelate excess Fe(III). After purifying with RNA Clean & Concentrator columns to remove excess reagents, the RNA was PAGE-purified using denaturing 8% polyacrylamide/7 M urea gels. Bands were located by scanning with a Typhoon imager (GE, Pittsburgh, PA) for fluorescein fluorescence, and excised gel slices were immersed in approximately 500 µl RNase-free H~2~O in non-stick tubes overnight at 4°C to elute the RNA. The RNA was purified from the eluate using RNA Clean & Concentrator columns and stored at −20°C. The yield of PAGE purification was 10--30% of the amount loaded on the gel, which was sufficient for multiple MOHCA-seq experiments.

Activation of radical source {#s4-3}
----------------------------

Before activating the radical source to produce spatially localized hydroxyl radicals, 3--4 pmol of folded RNA was prepared in 50 mM Na-HEPES, pH 8.0, and 10 mM MgCl~2~, as follows. First, the RNA was heated to 65°C in HEPES buffer in 8 µl for 3 min, then cooled to room temperature for 10 min; then 1 µl of 100 mM MgCl~2~ was added and the RNA was heated to 50°C for 5 min, then cooled to room temperature for 10 min. (For P4--P6, HEPES buffer and MgCl~2~ were added concurrently, and the RNA was incubated for 10 min at room temperature. For ligand-bound cyclic-di-GMP riboswitch aptamer samples, 100 pmol cyclic-di-GMP \[BioLog, Bremen, Germany\] was added before the first heating step for 10 µM in a 10 µl reaction. For ligand-bound glycine riboswitch ligand-binding domain samples, 100 nmol glycine \[Sigma, St. Louis, MO\] was added before the first heating step for 10 mM in a 10 µl reaction. For ligand-bound adenosylcobalamin \[AdoCbl\] riboswitch aptamer samples, 700 pmol AdoCbl \[Sigma\] was added before the first heating step for 70 µM in a 10 µl reaction, and all steps until post-fragmentation ethanol precipitation \[below\] were performed under low-light conditions. For 0 mM Mg^2+^ conditions, RNase-free H~2~O was added instead of MgCl~2~.) After folding, the radical source was activated by adding 1 µl 100 mM sodium ascorbate stock for a final concentration of 10 mM. A control reaction was also prepared with 1 µl RNase-free H~2~O added instead of ascorbate; this reaction was carried through all subsequent steps in parallel. After 5 to 30 min of incubation at room temperature (10 min was standard), 1 µl 100 mM thiourea was added to quench the Fenton reaction. The RNA fragments were ethanol precipitated as follows: First, 1 µl GlycoBlue (Life Technologies, Carlsbad, CA) and 1/10 vol (1.2 µl) of 3 M sodium acetate, pH 5.2 were added to the quenched reaction and mixed. Then, 3 vol (40 µl) of 100% ethanol chilled on dry ice were added, and the sample was mixed. Samples were spun down immediately in a tabletop microcentrifuge at maximum speed for 20 min, washed with 50 µl ice-cold 70% ethanol, then spun down again at max speed for 10 min. The supernatant was removed by pipetting and the pellets were allowed to dry, after which 15 µl RNase-free H~2~O was added and the pellet was allowed to dissolve for 10 min at room temperature.

Repair of 3′ ends {#s4-4}
-----------------

To remove 3′-phosphates left by hydroxyl radical strand scission events in the RNA backbone ([@bib7]; [@bib56]), the purified RNA fragments were treated with T4 polynucleotide kinase (T4 PNK) in conditions that promoted 3′-phosphatase activity ([@bib16]). Each end-repair reaction contained 14 µl of the RNA from the previous step (the remaining 1 µl was used for quality checks by capillary electrophoresis), as well as 50 mM Na-MES, pH 6.0, 10 mM MgCl~2~, 5 mM DTT, 5 µM ATP, and 10 units T4 PNK (NEB), in a 20 µl reaction volume and was incubated at 37°C for 30 min. After end-repair, RNAs were ethanol precipitated as above, except with 0.5 µl GlycoBlue, 2.05 µl 3 M sodium acetate, pH 5.2, and 68 µl 100% ethanol chilled on dry ice. The dried pellets were resuspended in 5.2 µl RNase-free H~2~O. The T4 PNK reaction was necessary and sufficient for ligation of a pre-adenylated ssDNA universal adapter sequence to the radical-cleaved fragments (see next section), based on experiments with PAGE-purified RNA fragments cleaved by hydroxyl radicals from FeEDTA in solution. The ligation efficiency after T4 PNK treatment was ∼50%, suggesting that non-phosphate end products of strand scission, such as 3′-phosphoglycolates, may not be removed by T4 PNK; however, the yield of ligated product was still sufficient for reverse transcription using limiting amounts of sequencing primers.

Ligation of ssDNA universal adapter sequence {#s4-5}
--------------------------------------------

To prepare the fragmented RNA for reverse transcription, a pre-adenylated and 3′-blocked ssDNA universal adapter sequence (Universal miRNA cloning linker, NEB) was ligated to the 3′-end of the end-repaired fragments. Each ligation reaction contained 4.9 µl of the RNA from the previous step (the remaining 0.3 µl was used for quality checks by CE), as well as 1× T4 RNA ligase buffer (NEB), 15% PEG 8000, 4--5 pmol ssDNA adapter, and 200 U T4 RNA ligase 2 truncated, K227Q or KQ mutant (NEB), in a 10 µl reaction volume. The reactions were incubated at 4°C for 12 hr, followed by heat inactivation at 65°C for 20 min. After ligation, reaction volumes were supplemented with 50 µl RNase-free H~2~O, and RNAs were purified from the reaction using RNA Clean & Concentrator columns, which also removed excess ssDNA adapter. Ligation was assayed using 5% of the purified sample by observing the mobility shift of the full-length RNA on CE. Mobility shifts of radical-cleaved fragments were not directly observed in this quality check but were observed in pilot experiments, as described above.

Reverse transcription with sequencing primers (first adapter) {#s4-6}
-------------------------------------------------------------

After ligation of the ssDNA adapter, RNAs were reverse transcribed with sequencing primers containing, in 5′ to 3′ order, a 5′-fluorescein modification, the Illumina TruSeq Universal adapter, 12-nucleotide barcodes (sequence-balanced in sets of 4 primers), and a primer for the ssDNA adapter sequence on the 3′-end (sequence listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Three of the four primers were used for reverse transcription of the ascorbate-treated sample and the remaining primer was used for reverse transcription of the no-ascorbate control sample. Each 15 µl reverse transcription reaction contained 250 fmol sequencing primer (which is limiting compared to the ∼2--3 pmol of RNA remaining at this stage), 1× First Strand buffer (Life Technologies), 5 mM DTT, 0.8 mM dNTPs, and 120 U SuperScript III (Life Technologies) and was incubated at 55°C for 30 min. To degrade the RNA templates, 5 µl of 0.4 M NaOH was added and the samples were incubated at 90°C for 3 min. After cooling on ice for 3 min, the cDNA samples were neutralized by addition of 1 µl of an acid quench (2 ml 5 M NaCl, 2 ml 2 M HCl, and 3 ml 3 M Na-acetate) and then purified by incubating with DynaBeads magnetic beads (Life Technologies) conjugated to double-biotin-labeled ssDNA complementary to the TruSeq adapter. For the glycine riboswitch ligand-binding domain with K-turn construct, the cDNA samples after RNA hydrolysis and neutralization were split in half. One half was purified as described above, and the other was purified using AMPure XP beads (Beckman Coulter, Indianapolis, IN), to provide size-selection for larger fragments corresponding to tertiary proximities between more distant sequence positions. Approximately, 65--75% of the sequencing primer was extended in the reverse transcription reactions, based on CE detection and quantification of 'null ligation' reads (consisting of the second sequencing adapter ligated directly to the sequencing primer) after paired-end sequencing.

Ligation of second sequencing adapter {#s4-7}
-------------------------------------

The second sequencing adapter ("Second ligation adapter 1", listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}), derived from the TruSeq Indexed adapter with a 5′-phosphate (to enable ligation to the cDNA) and a 3′-phosphate (to block circularization), was ligated onto the 3′-ends of the cDNAs. The four cDNA samples for each RNA/condition were pooled prior to the ligation reaction. Each 50 µl ligation reaction contained 1.25 µM adapter, 1× CircLigase buffer (Epicentre, Madison, WI), 50 µM ATP, 2.5 mM MnCl~2~, 4% PEG 1500, and 250 U CircLigase I (Epicentre) and was incubated at 68°C for 2 hr, followed by heat inactivation at 80°C for 10 min. The samples were purified by DynaBeads as above with magnetic separation, and a fraction of the sample was run on a capillary electrophoresis machine (Applied Biosystems, Foster City, CA) with co-loaded fluorescein-labeled standards and analyzed using HiTRACE ([@bib79]) to estimate the concentration of ligated cDNA by comparing the total intensities of ligated cDNAs to the total intensity of the standard. We observed approximately 50% ligation yield from the CircLigase reaction, consistent with earlier work ([@bib61]). For the glycine riboswitch ligand-binding domain with K-turn construct, the DynaBead-purified samples were ligated with \"Second ligation adapter 1\" as described above, while the AMPure XP-purified samples were ligated with a separate sequencing adapter (\"Second ligation adapter 2\", listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). This allowed multiplexed sequencing of the DynaBead- and AMPure XP-purified sample libraries.

Sequencing {#s4-8}
----------

The MOHCA-seq cDNA libraries were sequenced using either 50-cycle MiSeq v2 kits or 150-cycle MiSeq v3 kits on Illumina MiSeq instruments or using an Illumina HiSeq 2500 instrument (Elim Biopharmaceuticals, Hayward, CA). For runs using MiSeq v2 kits, the following protocol was used to prepare the library for sequencing: beads harboring 25 fmol of single-stranded library fragments, usually about 1/5 of the final library volume after ligation of the second adapter, were mixed with 2.5 fmol of PhiX dsDNA control (Illumina, Inc., Hayward, CA) and EB buffer (Qiagen, Venlo, Netherlands) to 5 µl total. Then, 5 µl of 0.2 N NaOH was added and the fragments were eluted for 10 min at room temperature. The supernatant of the magnetic beads was diluted into chilled HT1 buffer (10 µl added to 990 µl HT1), and then diluted again (375 µl added to 225 µl HT1) before loading all 600 µl onto MiSeq kits following manufacturer instructions. Paired-end sequencing involved 51 and 25 sequencing cycles for the first and second reads, respectively. For runs using MiSeq v3 kits, the following protocol was used to prepare the library for sequencing: beads harboring 32 fmol of single-stranded library fragments were mixed with 4.2 µl of 95% formamide and 10 mM EDTA and heated at 90°C for 2 min and 40 s, then cooled at room temperature for several minutes. The beads were magnetically separated, and 4 fmol of PhiX dsDNA control (Illumina) was added to the isolated supernatant. Then, 5 µl of 0.2 N NaOH was added and the samples were denatured for 10 min at room temperature. This sample was diluted into chilled HT1 buffer (10 µl added to 990 µl HT1) and 600 µl of this dilution was loaded onto MiSeq kits following manufacturer instructions. Paired-end sequencing involved 51 and 51 sequencing cycles for the first and second reads, respectively.

The FASTQ data generated by sequencing were processed with the MAPseeker v1.2 software (accessible through the RMDB server at <http://rmdb.stanford.edu/tools/>), giving final text files in RDAT format corresponding to the number of fragments observed for each pair of possible cleavage and oxidation position (corresponding to 5′ and 3′ positions of cDNA fragments). Our sequencing runs generally produced around 15--20 million total reads, of which around 60--80% contained the ssDNA adapter RT priming site and aligned to the RNA sequence in read 1, and 25--35% aligned to the RNA sequence in both read 1 and read 2. Approximately, 25% of aligned reads corresponded to control reactions with radical sources but without ascorbate treatment, while 75% of aligned reads corresponded to the ascorbate-treated, fragmented RNA, as expected from our method of dividing the ascorbate-treated sample into three fractions for reverse transcription. 25--35% of reads containing the RT priming site were null ligations of unextended reverse transcription primer to the second sequencing adapter.

For the glycine riboswitch ligand-binding domain with leader sequence, the raw data for the DynaBead-purified and AMPure XP-purified (size-selected) libraries were combined as follows: the sum of the signal at each sequence separation (along the diagonals of the 2D map) was calculated for each data set. For sequence separations between 50 and 100, the signal was averaged across consecutive bins of 2; above 100, the signal was averaged across bins of 10. Then, to account for size-selection by AMPure XP purification, the ratio of AMPure XP signal to DynaBead signal at each sequence separation was calculated and the AMPure XP signal was 'rebalanced' by multiplying it by the maximum AMPure XP/DynaBead ratio and then dividing by AMPure XP/DynaBead ratio at that sequence separation. Finally, the rebalanced AMPure XP data set was combined with the DynaBead data set by taking the mean (weighted by the inverse error squared) between the data sets. The raw data have been deposited in the RMDB with the following accession IDs:

P4-P6: TRP4P6_MCA_0001-0004

c-di-GMP riboswitch aptamer with 10 µM c-di-GMP: CDIGMP_MCA_0002

c-di-GMP riboswitch aptamer with 0 µM c-di-GMP: CDIGMP_MCA_0003

c-di-GMP riboswitch aptamer with 10 µM c-di-GMP and 0 mM Mg^2+^: CDIGMP_MCA_0006

c-di-GMP riboswitch aptamer with 0 µM c-di-GMP and 0 mM Mg^2+^: CDIGMP_MCA_0007

Glycine riboswitch ligand-binding domain with 10 mM glycine: GLYCFN_MCA_0002

Glycine riboswitch ligand-binding domain with 0 mM glycine: GLYCFN_MCA_0003

Glycine riboswitch ligand-binding domain including leader, with 10 mM glycine: GLYCFN_KNK_0005

Glycine riboswitch ligand-binding domain including leader, with 0 mM glycine: GLYCFN_KNK_0006

Glycine riboswitch ligand-binding domain including leader, with 10 mM glycine and 0 mM Mg^2+^: GLYCFN_KNK_0009

Glycine riboswitch ligand-binding domain including leader, with 0 mM glycine and 0 mM Mg^2+^: GLYCFN_KNK_0010

AdoCbl riboswitch aptamer with 70 µM AdoCbl: RNAPZ6_MCA_0002

AdoCbl riboswitch aptamer with 0 µM AdoCbl: RNAPZ6_MCA_0003

AdoCbl riboswitch aptamer (A124U/A125U mutant) with 70 µM AdoCbl: RNAPZ6_MCA_0006

AdoCbl riboswitch aptamer (A124U/A125U mutant) with 0 µM AdoCbl: RNAPZ6_MCA_0007

Class I ligase: CL1LIG_MCA_0001-0003

Lariat-capping ribozyme: RNAPZ5_MCA_0001-0002

HoxA9 5′-UTR 957--1132 domain: HOXA9D_MCA_0001

Quantification of oxidative damage {#s4-9}
----------------------------------

To evaluate the rates of strand scission and reverse transcription-terminating modifications, we quantified data from both paired-end sequencing and CE for the model hairpin RNA shown in [Figure 2B](#fig2){ref-type="fig"}, which contained a single radical source at U13 (blue and orange bars, [Figure 2D](#fig2){ref-type="fig"}). As a background control, we quantified data collected in parallel on a sample that did not have a tethered radical source but was otherwise treated identically (gray bars, [Figure 2D](#fig2){ref-type="fig"}).

To quantify strand scission events from sequencing data, we calculated the sum of all counts for fragments that shared the same ssDNA adapter ligation site, giving a projection of the raw counts after MAPseeker analysis ([Figure 2D](#fig2){ref-type="fig"}, top center). We then normalized the counts at each position by the number of counts for all fragments that were ligated at the 3′ end of the RNA, giving the fraction modified at each position. For an independent measurement of strand scission, we also ran a fraction of the same sample on CE, after radical source activation but before end-repair, and quantified the observed 5′-end labeled cleavage products using HiTRACE ([@bib79]) ([Figure 2D](#fig2){ref-type="fig"}, top). One residue position (marked by \*, [Figure 2D](#fig2){ref-type="fig"}) overlapped with a peak corresponding to bleed-through fluorescence from the reference channel, so the quantification of strand scission at that position is uncertain. The strand scission profiles from sequencing and CE are similar, showing fragmentation both near the position of the radical source and on the strand of the helix complementary to the radical source ([Figure 2D](#fig2){ref-type="fig"}, top and top center). We calculated the rate of strand scission from the CE and sequencing data by taking the sum of the fraction modified over all internal cleavage sites, excluding the reference bleed-through peak from CE and a high-background peak from the sequencing data (marked by \*, [Figure 2D](#fig2){ref-type="fig"}). The rate of strand scission was similar between the CE and sequencing data ([Figure 2E](#fig2){ref-type="fig"}).

To quantify reverse transcription stops from sequencing data, we calculated the sum of all raw counts for fragments with stops at the same position after MAPseeker analysis. To account for reverse transcriptase attenuation, we normalized the signal at each position by the total counts for all fragments that were ligated 3′ of that position and were terminated at that position or 5′ of that position, analogous to the exact correction applied for CE data ([Figure 2D](#fig2){ref-type="fig"}, bottom) ([@bib79]). For an independent measurement of reverse transcription stops, we also ran a fraction of the same sample on CE, after reverse transcription with sequencing primers but before ligation of the second sequencing adapter, and quantified the reactivity of each position using HiTRACE ([@bib79]) ([Figure 2D](#fig2){ref-type="fig"}, bottom center). The reverse transcription stop profiles from sequencing and CE are similar, showing reverse transcription-terminating events on the strand of the helix complementary to the radical source, as well as a stronger termination event at the location of the radical source ([Figure 2D](#fig2){ref-type="fig"}, bottom center and bottom). We calculated the rate of reverse transcription stops from the CE and sequencing data by taking the sum of the fraction modified over all stop sites, excluding the signal at residue 13 because the reactivity at that position is due to the tethered radical source and not oxidative modifications. The rate of RT stops was similar between the CE and sequencing data and was at least sixfold higher than the rate of strand scission ([Figure 2E](#fig2){ref-type="fig"}).

MOHCA-seq data analysis {#s4-10}
-----------------------

### General MOHCA-seq analysis framework {#s4-10-1}

Analysis of MOHCA-seq data requires modeling backgrounds, modulation from reverse transcription attenuation, and sources of error. Here, we outline a general analysis framework for MOHCA-seq experiments, with the following section describing a statistical procedure developed to reach a numerical solution, that gave consistent proximity maps. The resulting processed proximity maps have been deposited in the RMDB with the following accession IDs:

P4--P6: TRP4P6_MCA_0000

c-di-GMP riboswitch aptamer with 10 µM c-di-GMP: CDIGMP_MCA_0000

c-di-GMP riboswitch aptamer with 0 µM c-di-GMP: CDIGMP_MCA_0001

c-di-GMP riboswitch aptamer with 10 µM c-di-GMP and 0 mM Mg^2+^: CDIGMP_MCA_0004

c-di-GMP riboswitch aptamer with 0 µM c-di-GMP and 0 mM Mg^2+^: CDIGMP_MCA_0005

Glycine riboswitch ligand-binding domain with 10 mM glycine: GLYCFN_MCA_0000

Glycine riboswitch ligand-binding domain with 0 mM glycine: GLYCFN_MCA_0001

Glycine riboswitch ligand-binding domain including leader, with 10 mM glycine: GLYCFN_KNK_0003

Glycine riboswitch ligand-binding domain including leader, with 0 mM glycine: GLYCFN_KNK_0004

Glycine riboswitch ligand-binding domain including leader, with 10 mM glycine and 0 mM Mg^2+^: GLYCFN_KNK_0007

Glycine riboswitch ligand-binding domain including leader, with 0 mM glycine and 0 mM Mg^2+^: GLYCFN_KNK_0008

AdoCbl riboswitch aptamer with 70 µM AdoCbl: RNAPZ6_MCA_0000

AdoCbl riboswitch aptamer with 0 µM AdoCbl: RNAPZ6_MCA_0001

AdoCbl riboswitch aptamer (A124U/A125U mutant) with 70 µM AdoCbl: RNAPZ6_MCA_0004

AdoCbl riboswitch aptamer (A124U/A125U mutant) with 0 µM AdoCbl: RNAPZ6_MCA_0005

Class I ligase: CL1LIG_MCA_0000

Lariat-capping ribozyme: RNAPZ5_MCA_0000

HoxA9 5′-UTR 957--1132 domain: HOXA9D_MCA_0000

A MOHCA-seq product stemming from a radical cleavage event at nucleotide *j* and a radical source at nucleotide *i* corresponds to a sequence *i + 1* to *j* − *1* ligated between the two adapters necessary for paired-end Illumina sequencing. The frequency *F*~*ij*~ of such products is related to the proximity of *i* and *j* but is modulated by the actual distribution of radical sources, for example, primarily at adenosines for 2′-NH~2~-dATP-incorporating transcripts. The frequency is also suppressed by signal attenuation for long sequence separations *j* − *i* due to the possibility of reverse transcription termination between *i* and *j*. A master expression for these MOHCA-seq frequencies is:$$F_{ij} = {\sum\limits_{s}{p_{i}^{s}\left( {1 - p_{i + 1}^{s}} \right)\left( {1 - p_{i + 2}^{s}} \right)\ldots\left( {1 - p_{j-1}^{s}} \right)q_{j}^{s}\varepsilon\left( s \right)}}\text{,}$$with *s* indexing the possible source positions (0, 1, ... *N* with *s =* 0 corresponding to no source) and *ε*(*s*) the fraction of transcripts containing a source at *s*. Values $p_{i}^{s}$ give the probability that a reverse-transcription terminating event occurs at the nucleotide immediately 3′ to *i* for a transcript with source at *s*, and values $q_{j}^{s}$ give the probability of a cleavage event between *j* − 1 and *j* for a transcript with source at *s*. This expression simplifies in the limit of no background processes and low-oxidative damage rates (including radical-induced strand scission and nucleobase oxidation) ($p_{i}^{s},q_{j}^{s} \ll 1$, except at $p_{i}^{s = i} = 1$, corresponding to a reverse transcriptase stop at the site of radical source attachment). In that limit, [Equation 1](#equ1){ref-type="disp-formula"} reduces to:$$F_{ij} = q_{j}^{i}\varepsilon\left( i \right),$$

That is, the observed frequencies provide a direct readout of the probability that a source at *i* leads to radical cleavage at position *j*. This was the limit assumed in prior gel-based MOHCA analysis based on reading out *i* through cleavage of phosphorothioate tags associated with the radical sources. In the present MOHCA-seq protocol, we found empirically that the reverse transcription readout of *i* led to a more complete portrait of the proximity map, including information at nucleotides *i* at which radical sources were not attached. Indeed, increasing the incorporation rate of radical sources or the time of ascorbate-induced radical damage produced higher signal-to-noise data sets with clear proximity map signals, despite bringing the analysis away from the regime of single-hit incorporation and damage ([Figure 2---figure supplements 1, 2](#fig2s1 fig2s2){ref-type="fig"}). The extra information was derived from oxidative damage events that did not lead to backbone cleavage encapsulated in the term $p_{i}^{s}$ ([Figure 2B--E](#fig2){ref-type="fig"}; also, compare [Figure 1D](#fig1){ref-type="fig"} to initial MOHCA-gel data \[[@bib23]\], these events were previously invisible to gel-based analysis), but required a more advanced analysis to elicit the signal from the raw data.

In the general case, the number of observed frequencies *F*~*ij*~ is on the order of *N(N* − 1*)/*2, whereas the total number of model parameters ε(*s*), $p_{i}^{s}$, and $q_{j}^{s}$ is substantially higher (\>2N^2^), leading to an ill-posed problem. However, basic chemical considerations reduce the number of parameters. First, we assume that the cleavage fraction that allows ssDNA adapter ligation, $q_{j}^{s}$, is composed of a 'background' rate of cleavage *b*~*j*~ that is independent of source *s* but can vary with nucleotide j (e.g., due to inline attack during the fragmentation reaction), and additional, correlated cleavage due to hydroxyl radical-induced strand scission events (the desired MOHCA-seq signal), parameterized by $\pi_{j}^{s}$:$$\text{Cleavage at }j\text{ from source }s = q_{j}^{s} = 1 - \left( {1 - b_{j}} \right)\left( {1 - \pi_{j}^{s}} \right) \approx b_{j} + \pi_{j}^{s}\text{.}$$

Second, we assume that the stopping events $p_{i}^{s}$ are composed of two components: (1) a background rate *r*~*i*~ of uncorrelated oxidative damage (e.g., due to hydroxyl radicals from FeEDTA that has self-cleaved from the RNA during ascorbate treatment, which would provide background similar to standard FeEDTA hydroxyl radical footprinting) and (2) additional, correlated oxidative damage due to hydroxyl radicals generated at source *s*, which is tethered to the RNA (the desired MOHCA-seq signal), $\pi_{i}^{s}$:$$\text{Stop at }i\text{ from source }s = p_{i}^{s} = 1 - \left( {1 - r_{i}} \right)\left( {1 - \rho_{i}\pi_{i}^{s}} \right) \approx r_{i} + \rho_{i}\pi_{i}^{s}\text{.}$$

In [Equations 3, 4](#equ3 equ4){ref-type="disp-formula"}, a reduction in the number of parameters arises from assuming that oxidative damage events producing reverse transcription stops occur at rates proportional to backbone cleavage rates by a factor $\rho_{i}$. That is, $\pi_{i}^{s}$ parameterizes the local effective concentration of radicals at *i* from source *s*, and the partitioning of these radicals into events that lead to cleavage (contributing to $q_{i}^{s}$) vs total damage that can terminate reverse transcription (contributing to $p_{i}^{s}$) is dependent on the chemical environment of the site *i* and not on source *s*. The total number of parameters thus reduces from greater than 2N^2^ to *N(N* − 1*)/*2 for $\pi_{i}^{s}$ and 3*N* for *b*~*j*~, *r*~*i*~, and ε(*s*). By further enforcing positivity of each of these parameters and assuming that $\pi_{i}^{s}$ is sparse, that is, that each nucleotide gives non-negligible cleavage at a number of residues smaller than *N*, the number of parameters is reduced to below the number of observables, and the problem becomes well-posed. Requiring sparsity of the proximity map is similar to assumptions used in solvent flattening and other density modification approaches in crystallography ([@bib73]).

Determining proximity information from raw observables still requires solving a complex system of non-linear equations. We found that direct least-squares optimization of the thousands of variables $\pi_{i}^{s}$ to fit the observed *F*~*ij*~, including Laplace priors to enforce sparsity, required hours even with state-of-the-art numerical optimizers. We instead developed a rapid, iterative strategy to carry out the solution, as described next.

COHCOA {#s4-11}
------

A closure-based •OH correlation analysis (COHCOA) estimates a solution to [Equation 1](#equ1){ref-type="disp-formula"} to determine a two-point correlation function that is directly read out by MOHCA-seq. In the limit that the fraction damaged at any single nucleotide is smaller than one,$$\begin{array}{ll}
F_{ij} & {\approx {\sum\limits_{s}\left\lbrack {p_{i}^{s}q_{j}^{s} - {\sum\limits_{i < m < j}{p_{i}^{s}p_{m}^{s}q_{j}^{s}}}} \right\rbrack}\varepsilon\left( s \right)} \\
 & {= \left\langle {p_{i}q_{j}} \right\rangle - {\sum\limits_{i < m < j}\left\langle {p_{i}p_{m}q_{j}} \right\rangle}\text{,}} \\
\end{array}$$where the bracket notation refers to a summation over sources:$$\left\langle f \right\rangle = {\sum\limits_{s}{\varepsilon\left( s \right)}}f^{s}\text{,}$$and terms beyond second order are neglected. The effects of the radical cleavage result in a one-dimensional damage profile *R*~*i*~ (corresponding to uncorrelated oxidative damage) and cleavage profile *B*~*j*~ and a two-point correlation function *Q*~*ij*~ (corresponding to correlated oxidative damage or radical source locations), which encodes the desired proximity map:$$\begin{array}{l}
{B_{j} = b_{j} + \left\langle \pi_{j} \right\rangle} \\
{R_{i} = r_{i} + \rho_{i}\left\langle \pi_{i} \right\rangle} \\
{Q_{ij} = \rho_{i}\left\lbrack {\left\langle {\pi_{i}\pi_{j}} \right\rangle - \left\langle \pi_{i} \right\rangle\left\langle \pi_{j} \right\rangle} \right\rbrack\text{,}} \\
\end{array}$$leading to the equation$$F_{ij} \approx R_{i}B_{j} + Q_{ij} - {\sum\limits_{i < m < j}\left( {R_{i}R_{m}B_{j} + R_{m}Q_{ij} + R_{i}Q_{mj} + {\rho_{m}Q}_{im}B_{j}} \right)},$$

In the derivation of (8), we have dropped higher order terms corresponding to neglecting higher cumulants of the damage function (e.g., the three-point cumulant $J_{imj} = \left\langle {\pi_{i}\pi_{m}\pi_{j}} \right\rangle - \left\langle {\pi_{i}\pi_{m}} \right\rangle\left\langle \pi_{j} \right\rangle - \left\langle {\pi_{i}\pi_{j}} \right\rangle\left\langle \pi_{m} \right\rangle - \left\langle {\pi_{j}\pi_{m}} \right\rangle\left\langle \pi_{i} \right\rangle + 2\left\langle \pi_{i} \right\rangle\left\langle \pi_{j} \right\rangle\left\langle \pi_{m} \right\rangle$) to match the lowest order assumed in [Equation 5](#equ5){ref-type="disp-formula"}. We also note that stops due to the possibility of more than one radical source attached to the transcript (neglected in the derivation above) can be modeled accurately, to first order, by including a rate ε(*i*) within the general 'background' stopping rate *R*~*i*~ (not shown). In general, all processes that lead to stops or cleavage across all transcripts are subsumed into *R*~*i*~ and *B*~*j*~. As a corollary to this simplification, however, this framework does not seek or enable deconvolution of the separate contributions to each of these background rates.

In practice, [Equation 8](#equ8){ref-type="disp-formula"} can give unphysical negative values if the subtracted summand becomes large. Following a strategy used in, for example, reference interaction site models for solvation, we 'close' the expansion by solving an equation system that is equal to (8) at lowest order, exact in certain limits, and guaranteed to give positive results:$$F_{ij} = A_{ij}\left( {R_{i}B_{j} + Q_{ij}} \right),$$$$A_{ij} = {\prod\limits_{i < m < j}\left( {1 - R_{m}} \right)}\left( {1 - \frac{R_{i}Q_{mj}}{F_{ij}}} \right)\left( {1 - \frac{\rho Q_{im}B_{j}}{F_{ij}}} \right)\text{.}$$

Intuitively, many of the observed products *F*~*ij*~ are due to uncorrelated cleavage events *B*~*j*~ and reverse transcription stop events *R*~*i*~, which produce a 'plaid' background pattern. On top of this background is the desired two-point correlation signal *Q*~*ij*~*,* which is non-zero only when nucleotides *i* and *j* have both been chemically modified by the same proximal source*.* Modulating these signals is an attenuation factor *A*~*ij*~*,* which parameterizes the loss of signal, as a reverse transcriptase must polymerize from *j* back to *i*. This factor depends on the general background stop rate *R*~*i*~, but also includes two additional terms representing the possibility for additional reverse-transcription-stopping damage correlated with the observed cleavage event at *j* and the observed stopping event at *i*. (For simplicity and based on separate experiments, we fixed $\rho$, the ratio of chemical modification to backbone cleavage, as a constant at 2.5; changing this value from 1 to 5 gave indistinguishable results.) We note that the [Equation 9a,b](#equ9 equ10){ref-type="disp-formula"} is exact in the case of negligible *Q*~*ij*~; see references ([@bib5]; [@bib42]; [@bib44]).

The [Equations 9](#equ9 equ10){ref-type="disp-formula"} are solved through iteration in a single script cohcoa_classic.m available in the MAPseeker package. A starting estimate of *R*~*i*~ and attenuation matrix *A*~*ij*~ comes from data corresponding to cleavages in the 3′-flanking region, which is initially assumed to not give specific contacts with the target RNA domain. One-dimensional 'background' profiles *R*~*i*~ and *B*~*j*~ are determined, which best fit the attenuation-corrected data *F*~*ij*~/*A*~*ij*~. Subtracting the resulting background matrix *R*~*i*~*B*~*j*~ from observed *F*~*ij*~ results in an initial solution for *Q*~*ij*~ via [equation (9a)](#equ9){ref-type="disp-formula"}. Any point of *Q*~*ij*~ that is negative is reset to zero, and these *R*~*i*~, *B*~*j*~, and *Q*~*ij*~ give an updated solution for the attenuation matrix *A*~*ij*~ via [equation (9b)](#equ10){ref-type="disp-formula"}. New estimates of *R*~*i*~ and *B*~*j*~ are derived from fitting *F*~*ij*~*/A*~*ij*~ − *Q*~*ij*~ via equation (9d) and the process is iterated until convergence. This procedure does not require assuming symmetry of the two-point correlation function *Q*~*ij*~, but in the end returns an estimate of this matrix only for (*i* \< *j*), where there are data *F*~*ij*~. Propagating Poisson counting errors on *F*~*ij*~ in [Equation 9b](#equ10){ref-type="disp-formula"} gives standard errors on *A*~*ij*~, and combining these errors in quadrature with the errors on *F*~*ij*~ in [Equation 9a](#equ9){ref-type="disp-formula"} gives final error estimates for the two-point correlation function *Q*~*ij*~. Empirically, 20 or fewer iteration cycles lead to convergence for all data sets tested; 40 iterations have been used in this study to ensure convergence of final *Q*~*ij*~ values within 1% (taking less than 1 min on a MacBook Pro 2.8 GHz Intel Core i7 running MATLAB 2012B). A comparison of raw counts and COHCOA-analyzed data is shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.

For visualization of the COHCOA-analyzed data as 2D proximity maps, we first applied a filter to remove points with signal-to-noise ratio \< 1, then applied a 2D smoothing algorithm to aid visualization of the strongest features. Finally, we calculated the mean of the filtered and smoothed data with all negative values set to 0, then scaled the data by dividing by 5 times this value.

One-dimensional chemical mapping of AdoCbl riboswitch aptamer {#s4-12}
-------------------------------------------------------------

We performed one-dimensional (1D) chemical mapping of wild-type AdoCbl riboswitch aptamer and the A124U/A125U double mutant using dimethyl sulfate (DMS), 1-cyclohexyl-\[2-morpholinoethyl\] carbodiimide metho-p-toluene sulfonate (CMCT), and 1-methyl-7-nitroisatoic anhydride (1M7, SHAPE reagent), as described previously ([@bib42]; [@bib20]; [@bib44]). Briefly, RNAs were transcribed as above with unmodified NTPs only, then PAGE-purified as above on a denaturing 8% polyacrylamide/7 M urea gel, using UV-shadowing of a duplicate sample in an adjacent lane to avoid UV-induced damage ([@bib43a]). For 1D chemical mapping, 1.2 pmol of RNA was folded with AdoCbl as described above in 15 µl samples, then modified by adding 5 µl of freshly prepared modification reagent (0.5% DMS, 10.5 mg/ml CMCT, or 4.2 mg/ml 1M7) and incubating at room temperature for 10 min (1M7) or 15 min (DMS, CMCT). RNase-free H~2~O was added to a no-modification control reaction. Reactions were quenched and RNA was purified and reverse-transcribed as described previously ([@bib70]), then cDNAs were purified, eluted from magnetic beads, and analyzed on an ABI3130xl capillary electrophoresis instrument (Applied Biosystems) ([@bib70]). Sequencing ladders were also prepared in parallel ([@bib70]). The HiTRACE software package version 2.0 (MATLAB toolbox available at <https://github.com/hitrace> \[[@bib79]\] and web server available at <http://hitrace.org> \[[@bib40]\]) was used to analyze CE data as described previously, including normalization against GAGUA reference hairpins included at the 5′- and 3′-ends of each construct ([@bib44]; [@bib70]).

Computational modeling {#s4-13}
----------------------

### De novo RNA modeling with M^2^ and MOHCA-seq constraints {#s4-13-1}

We used the Rosetta software (version r56277) to model all RNAs of interest in three steps (software available at <https://www.rosettacommons.org/software>) ([@bib18]). Modeling for the AdoCbl riboswitch aptamer was performed with some differences, as noted below. First, we pre-assembled the helix regions of the RNAs using FARNA with full-atom refinement (FARFAR), using the python script helix_preassemble_setup.py. Pre-assembling helices reduced overall computational expense by removing sampling of secondary structure elements. For each helical region, 100 FARFAR models were generated, with the following sample Rosetta command line:

rna_denovo -nstruct 100 -params_file helix.params -fasta helix.fasta -out:file:silent helix0.out -include_neighbor_base_stacks -minimize_rna true -rna::corrected_geo -score:rna_torsion_potential RNA11_based_new -geom_sol_correct_acceptor_base -chemical::enlarge_H\_lj -score:weights rna/rna_helix -cycles 1000 -output_res_num 136-142 221-227

For small RNAs, such as the c-di-GMP riboswitch aptamer, we allowed conformational sampling of helix elements by omitting helix pre-assembly and instead including pseudo-energy constraints (as described below) for secondary structure elements.

Second, we performed low-resolution modeling using the pre-assembled helices and tertiary constraints derived from maxima in the 2D MOHCA-seq proximity map. Tertiary constraints were determined by identifying peaks from analyzed data that were (1) distinguishable from the local background signal by unbiased inspection and (2) not attributable to secondary structure, based on secondary structures inferred by M^2^ ([@bib41]). This produced a list of pairs of residues that were suggested to be spatially proximal by the MOHCA-seq data (tabulated in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). We sorted the selected pairs for each RNA into strong and weak hits based on the apparent intensity of the signal relative to the background. For each pair of residues showing a strong MOHCA-seq hit, we constrained the distance between the O2′ of first residue and C4′ of the second residue using a potential of the following form (see graph in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}):$$S\left( x \right) = 3x^{2} - 2x^{3},$$$$E\left( d \right) = \begin{cases}
{4\left( {1 - S\left( {d/15} \right)} \right)} & {\text{if }0 \leq d < 15} \\
{4S\left( {d/15 - 1} \right)} & {\text{if }15 \leq d < 30} \\
{4 + 36S\left( {d/30 - 1} \right)} & {\text{if }30 \leq d < 60} \\
40 & {\text{if }d \geq 60} \\
\end{cases}.$$

Here, *S* is the smoothstep function, *d* is the distance between the atom pair, and *E* is the constraint potential in Rosetta energy units. For residue pairs with a weak MOHCA-seq signal, we applied a constraint potential of the same shape but weaker amplitude (1/5 of the original potential).

With the constraints and the pre-assembled helices, we performed an FARNA simulation to generate a large number of low-resolution Rosetta models (ranging from 10,000 to 60,000). For cases in which other experimental constraints (hydroxyl radical footprinting for the P4--P6 domain and class I ligase; tertiary information from M^2^ on the P4--P6 domain) were available, these constraints were also included in the modeling. To assess the importance of MOHCA-seq constraints for accurate modeling, we also performed modeling without MOHCA-seq constraints (M^2^/Rosetta modeling) using the same command lines as above but without the flags to input constraint files and stage constraints (--cst_file constraint and -staged_constraints, below). A sample Rosetta command line is shown below:

rna_denovo -nstruct 500 -params_file rna_params.params -fasta rna_fasta.fasta -out:file:silent rna.out -include_neighbor_base_stacks -minimize_rna false -native rna_native.pdb -in:file:silent helix0.out helix1.out helix2.out helix3.out helix4.out helix5.out helix6.out -input_res 1-8 19-26 12-17 122-127 42-46 84-88 55-61 113-119 62-66 72-76 79-82 89-94 111-112 --cst_file constraint -staged_constraints -cycles 20000 -output_res_num 1-127

In the final step, we refined models from the initial run that had low Rosetta low-resolution scores (within the lowest 1/6 of the models) using the high-resolution Rosetta score to obtain final minimized models. This was achieved using the rna_minimize Rosetta application:

rna_minimize -native rna_native.pdb -cst_fa_file constraint -params_file rna_params.params -skip_coord_constraints -in:file:silent 0.silent -out:file:silent rna_min.out

To find representative models, we clustered the lowest energy models (3% of the total refined models or 0.5% of the total number of the unrefined models), with a threshold (based on all-heavy-atom RMSD) chosen so as to give 1/6 of the clustered models in the most populous cluster, as in prior work ([@bib23]). The clustering was achieved by first finding the model (the 'cluster center') with the largest number of neighboring models within the RMSD threshold, then assigning these models to the first cluster (cluster 0). This process was then repeated to cluster all of the remaining models. The cluster center model represents the best tertiary structure prediction of the MCM pipeline. Clustering was performed using Rosetta, with the following command line:

cluster -in:file:silent silent.out -in:file:fullatom -out:file:silent_struct_type binary_rna -export_only_low false -out:file:silent cluster.out -cluster:radius 7

The RMSD threshold described above represents an estimate of the intra-cluster RMSD of the structure ensemble from the modeling. We used this intra-cluster RMSD to calculate an in situ RMSD estimate ('precision') of the ensemble to the 'true' structure. The in situ RMSD of the cluster center model to the 'true' structure can be stated as the distance in structure space between the 'true' structure and the cluster center. This can be conservatively estimated as the sum in quadrature of the RMSDs between (1) the 'true' structure and the most accurate member of the cluster and (2) this cluster member and the cluster center. The intra-cluster RMSD represents an upper bound on distance (2), and assuming that distance (1) is no greater than distance (2), the in situ RMSD of the cluster center to the 'true' structure is estimated as the intra-cluster RMSD multiplied by the square root of 2. This precision estimate is reported in [Table 2](#tbl2){ref-type="table"}. The accuracy of the ensemble was estimated using the RMSD of the cluster center of the largest cluster to the gold-standard crystal structure. The accuracy and precision of modeling for the AdoCbl riboswitch aptamer were determined slightly differently, as described below, to allow direct comparison to prior modeling efforts in the RNA-puzzle challenge.

As another measure of prediction confidence, we calculated the p-value of each final MCM and M^2^/Rosetta model using a previously described empirical formula that relates mean pairwise phosphate backbone RMSD to RNA length to allow for calculation of a prediction significance ([@bib32]). These values are reported for the benchmark RNAs in [Table 1](#tbl1){ref-type="table"}. Finally, we calculated the percentage of strong and weak MOHCA-seq constraints satisfied by our models (averaged over all models in each cluster) and the crystal structure. We defined a constraint as 'satisfied' if the O2′ of the first residue was within 30 Å of the C4′ of the second residue. The cluster center models produced by MCM modeling generally satisfied 80% or more of the strong constraints and 60% or more of the weak constraints. As expected, the models generally satisfied a greater percentage of constraints than the crystal structures; however, the percent of constraints satisfied was not correlated with the accuracy or precision of the models or with the level of cleavage observed in the proximity maps. As described in the main text, unsatisfied constraints could arise from structural perturbations due to radical source attachment, or conformational flexibility of the RNA, or the benzyl-thiourea linker tethering the radical source to the RNA backbone. The details of the modeling results and these statistics are listed in [Tables 1, 2](#tbl1 tbl2){ref-type="table"}.

For the AdoCbl riboswitch aptamer (RNA-puzzle 6) and the lariat-capping ribozyme (RNA-puzzle 5), we did not pre-assemble helices and instead used prebuilt RNA fragments that we previously generated during the RNA-puzzles challenges, as described in ([@bib49]). The prior models generated for the RNA-puzzles 5--6 challenges can be viewed on the RNA-puzzles website (<http://ahsoka.u-strasbg.fr/rnapuzzles/problems_past.html>). For the AdoCbl riboswitch aptamer, the pre-built fragments consisted of three models each of the P1 through P6, P7 through P8, and P10 through P11 regions. We modeled the AdoCbl riboswitch aptamer with three distinct combinations of these fragments, each containing one fragment of each region. To estimate the precision of MCM modeling for the AdoCbl riboswitch aptamer in the ligand-bound and ligand-free states, we calculated the average pairwise all-heavy-atom RMSD between the cluster centers of the largest clusters for the three modeling setups and used this as the intra-cluster RMSD for calculating the in situ precision estimate.

For the lariat-capping ribozyme, we used MCM to guide rebuilding of the peripheral regions of the structure, and RMSD accuracies to the crystal structure and constraint satisfaction percentages are reported separately for these peripheral regions and the full structure ([Tables 1, 2](#tbl1 tbl2){ref-type="table"}). RMSD accuracies of only the refined regions of the structure were calculated by aligning the models to the crystal structure using MAMMOTH with the distance threshold set to the default, 4 Å, and then computing the RMSD of the refined residues ([@bib54]). To estimate the precision of the refined regions, we performed the same alignment, comparing each cluster model to the cluster center, and used the highest RMSD as the intra-cluster RMSD. To calculate the percentage of constraints satisfied for the refined regions, we used only constraints that included at least one residue within the peripheral regions, to assess how MCM affected its orientation to both itself and to the rest of the structure. For global constraint satisfaction percentages, we used all constraints.

For the class I ligase, we calculated RMSD accuracies to the crystal structure and constraint satisfaction percentages separately for the ribozyme core (excluding the substrate helix) and the full structure. RMSD accuracies of the core by itself were calculated by aligning the core residues, including the active site (residues 28--114), of the models to the crystal structure using MAMMOTH with the distance threshold set to 20 Å, then computing the RMSD of the refined residues ([@bib54]). To estimate the precision of the core by itself, we performed the same alignment, comparing each cluster model to the cluster center, and used the highest RMSD as the intra-cluster RMSD. To calculate the percentage of constraints satisfied for the core by itself, we used only constraints for which both residues were in the core. For global constraint satisfaction percentages, we used all constraints.

For the ligand-free states of the c-di-GMP, glycine, and AdoCbl riboswitch aptamers, we performed modeling as above with pseudo-energy constraints from MOHCA-seq proximity maps collected in ligand-free conditions. Because the ligand-free states are expected to exhibit greater conformational heterogeneity, we omitted the clustering step and compared the minimized models with the lowest Rosetta energy scores for visualization. We found that for constructs with weak residual tertiary MOHCA-seq hits, such as the c-di-GMP riboswitch aptamer and glycine riboswitch ligand-binding domain with leader sequence, these lowest energy models included both compact or native-like conformations as well as extended and incorrectly folded conformations. For the AdoCbl riboswitch aptamer, we compared the cluster centers of the three independent modeling setups as a similar way of assessing heterogeneity between modeling runs. These comparisons are illustrated in [Figures 4C](#fig4){ref-type="fig"}, [5C](#fig5){ref-type="fig"}, [6B](#fig6){ref-type="fig"}.

For the HoxA9 IRES domain, we performed modeling with two secondary structures, one including the pseudoknot predicted by M^2^ and mutate-and-rescue, and one without the pseudoknot, predicted by only M^2^ data. When the pseudoknot was not specified in the secondary structure, a MOHCA-seq pseudo-energy constraint was included during modeling to reflect the proximity observed by the MOHCA-seq experiment (constraint pair in parentheses, [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Our modeling generated global structures for the domain with a similar core region between the models for the two secondary structures ([Figure 7C--D](#fig7){ref-type="fig"}). As an additional estimate of the modeling resolution, we calculated the RMSD between the cluster center for the top cluster modeled with and without the pseudoknot, in addition to the standard estimation of the precision for each top cluster, and found that the RMSD between cluster centers (19.5 Å) was similar to the precision within each cluster (19.5 Å and 19.8 Å for with and without pseudoknot, respectively) ([Table 2](#tbl2){ref-type="table"}).

All-heavy-atom RMSDs for RNA-puzzle models ([Figure 3D,F](#fig3){ref-type="fig"} and [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}) were calculated using the rna_score application in Rosetta with the following command line:

rna_score -s model.pdb -native native.pdb

where the native PDB was the crystal structure ([@bib55]; [@bib71]; [@bib80]). For the SAM-I/IV riboswitch aptamer (RNA-puzzle 8), the last six nucleotides at the 3′-end of the crystal RMSD did not match the RNA-puzzle sequence, so the RMSD was calculated over the regions of matching sequence, residues 1--91. For the T-box/tRNA^Gly^ (RNA-puzzle 10), the first nucleotide and last nine nucleotides of the tRNA in the co--crystal structure did not match the RNA-puzzle sequence, so the RMSD was calculated over the regions of matching sequence, residues 6--66; the RMSD calculations included all T-box residues.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for resubmitting your work entitled "Consistent global structures of complex RNA states through multidimensional chemical mapping" for further consideration at *eLife*. Your revised article has been favorably evaluated by James Manley (Senior editor), the member of the Board of Reviewing Editors who oversaw the original review, and the three original peer reviewers. As you will see, all thought that the paper was significantly improved; thank you for the very conscientious revision. Please address the remaining concerns raised by referee 1 before uploading your final files.

*Reviewer \#1*:

The revised manuscript by Cheng et al. on modeling of RNA structures is greatly improved over the original submission. In particular, it is now possible to understand the method from the main text, and the controls and assumptions are explained more clearly. These explanations also better demonstrate the usefulness and potential of this method for probing and modeling RNA structures. Overall, this is very interesting and significant work.

I still have a few questions that were not fully addressed by the authors in their revisions.

Specific comments:

[Figure 3 A, B](#fig3){ref-type="fig"}: The authors now explain the effects of oxidative damage far more clearly. Nevertheless, the very high frequency of additional RT stops could have a negative effect on the modeling, which the authors should discuss. First, by generating reads that are shorter than those arising from RT stops at site of the tether, they inflate the number of short pairwise constraints. It is still not clear to me that these do not bias the modeling procedure. Second, some of these reads could arise from two damaged sites 5\' of the tether, producing false constraints.

In [Figure 3C, D](#fig3){ref-type="fig"}: Previous authors (e.g. Brenowitz et al.) reported a similar frequency of RT stops and strand cleavage, and not the 6-fold difference reported here. Could the authors comment on the reason for this difference? Is this because the authors use only ascorbate, rather than a combination of hydrogen peroxide and ascorbate? I am still puzzled by the claim that these additional RT stops arise from common base oxidation products, such as 8-oxoG or 5\'-HOC. Reverse transcriptases (and other DNA polymerases) are reported in the literature to bypass such lesions fairly easily.

In response to the reviewer comments, the authors provide better comparisons of models with and without the MOHCA constraints, but they didn\'t address how sensitive the models are to the number (and quality) of the constraints. If you leave out the "false" constraints, are the models better? If you include only half the number of "true" constraints, are the models significantly worse? This is certainly worth discussing and testing (if not now, in the future).

The comparison of liganded and free riboswitches in [Figures 6 and 7](#fig6 fig7){ref-type="fig"} are a nice demonstration that the method is robust enough to give some kind of prediction even when the RNA is not stably folded. The conclusion that the models represent the actual ensemble of unliganded RNA conformations, however, is untested, and probably incorrect. The authors should remove this claim from the discussion and figure legends. It is easy to see from [Figure 6 and 7](#fig6 fig7){ref-type="fig"} that the uncertainty in modeling the unliganded riboswitches comes from a lack of constraints, rather than an increase in the average distance between RNA helices or a greater variety of constraints. Moreover, they necessarily obtain native-like structures in the absence of ligand, because these are the only structures that are sufficiently coherent to produce self-consistent constraints. (These two pitfalls are analogous to the well-understood limitations of 3D models based on NMR NOEs.)

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The previous decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled "Consistent and blind inference of RNA tertiary folds through multidimensional chemical mapping" for consideration at *eLife*. Your full submission has been evaluated by James Manley (Senior editor), a Reviewing editor, and three peer reviewers, and the decision was reached after discussions between the reviewers. Based on our discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Timothy Nilsen (Reviewing editor); Hashim Al-Hashim (reviewer). Two reviewers remain anonymous.

We have received comments on your manuscript from three experts in the specific area of RNA structure analyses. As you will see one reviewer was enthusiastic about the work and recommended publication; however, the other two reviewers, while agreeing that the work was potentially important, raise significant concerns regarding the method you describe. These concerns include technical points as well as uncertainty regarding validation of the method. Given the substantive nature of the issues raised, we must decline your manuscript.

*Reviewer \#1*:

The authors describe an improved method for using high throughput sequencing and tethered hydroxyl radical cleavage to obtain distance constraints for RNA modeling. They offer an impressive array of successful examples, and also describe how the method is designed to work in tandem with their previously described mutate and map strategy for obtaining secondary structures. A large amount of work is presented in this paper. Although the pipeline is complicated and beyond the reach of most labs, it would represent a significant step forward, if it proves reliable over the long term. Below I outline some concerns about the presentation of the work and the basic premise of MOHCA-Seq.

The body of the manuscript is more of an advertisement than a description of what was done. The substance of the paper is in the Methods section, and the manuscript should be reorganized so that much more of the modeling strategy and data analysis is brought forward into the "Results" section. [Figure 1](#fig1){ref-type="fig"} and its supplements could be (ought to be) a substantial fraction of the "main" manuscript---this assessment is both a testament to the amount of work described in this paper, and a problem in that critical tests and examples of the method are buried.

Although the authors present many success stories, they do not describe the statistics on how many models are correct, how dependent the final models are on individual constraints (what happens when one leaves some out?), and so on. To help the reader judge the importance of the 3D MOHCA constraints, comparisons in the supplemental Tables 3 and 4 should be brought into the main text and possibly illustrated. A better discussion of the effects of noise, false distance constraints that arise from background cleavage of the RNA or other artifacts is needed.

My main concerns have to do with the distribution of the MOHCA-Seq reads and their interpretation as "distance constraints". In the main text (and supplement), the authors note that they observe additional sequence reads from arrest of RT at damaged (oxidized) nucleotides that lie between the radical source and the site of cleavage. First, the authors assume these "extra" stops arise from non-scissile base damage, but of course, they could arise from strand scission events. The authors write as if these are in different categories, but this distinction is meaningless as the reason for the RT stop can\'t be ascertained after the fact.

In [Equation 4](#equ4){ref-type="disp-formula"}, are the authors simply attempting to model the distribution of their data as arising from a component that depends on the frequency of tethered Fe(II)-EDTA complexes and a component that is independent of having tethered complexes? I presume this is the idea behind the COHCOA correlation analysis, which rightly ignores the distinction between "oxidative damage" and "cleavage". This could be explained more forthrightly.

On the other hand, as the total dose of Fe(II)EDTA-dependent hydroxyl radical cleavage increases, the frequency of stops at a cleaved residue will equal or exceed RT stops at the site of the tether. In this limit, any information about the pairwise correlation between the site of the tethered reagent and the site of cleavage will be lost, undermining the premise of the experiment. At what limit does this occur, and does this tendency already account for the very uniform map before COHCOA analysis?

Even when cleavage events are sparse, I had trouble understanding how the authors turn the distribution of RT stops into reliable distance constraints. Backbone cleavage arising from a tethered source of hydroxyl radical can be interpreted as a (blurred) vector between two residues. By contrast, sequence reads that start and end at two damaged or cleaved sites may arise when both residues are close to the radical source. However, one cannot be sure how close the sites are to each other, especially as one does not know where the Fe-EDTA was tethered. Presumably the inconsistencies arising from such ambiguities in the distance constraints are sorted out during the modeling, but what evidence do the authors have that this is the case? In the modeling section, it is stated that 60%-80% of constraints were satisfied by the best models; to what degree does this reflect the level of cleavage or specific types of non-random noise (see below)?

[Equation 3](#equ3){ref-type="disp-formula"} assumes a uniform rate of background cleavage *b*~*j*~. Of course, the background cleavage is almost certainly non-uniform. It is well known that certain residues will be more prone to hydrolysis (or RNase digestion) than others, and the resulting distribution of reads will appear similar to a genuine signal from a tethered Fe(II)EDTA. Is this type of non-random background addressed by using a mock-treated control? How is the information from the control incorporated into the data analysis? It would be great to see examples of data sets in which the iron was left out, or data sets on a long double-stranded RNA, and so on, to get an idea of how well the method works in these idealized or control examples.

Finally, a drawback of the original MOHCA was that the experimentally observed constraints were all short range with respect to the RNA sequence. A cutoff was applied so that these short-range constraints did not overwhelm the model building. A similar strategy is presumably used here: how sensitive are the models to this cutoff, and what is the practical limit on the size of the RNA that can be modeled by this method?

Reviewer \#2:

This manuscript describes important advances in high throughout structure modeling of RNA. The authors show that integrating distance contact information that can readily be obtained from multiplexed hydroxyl radical cleavage analysis with powerful methods developed by the group (mutate-and-map secondary structure analysis and Rosetta modeling), the tertiary fold of large and complex RNAs can be determined with an estimated accuracy of 1 nm. The authors demonstrate their approach on a variety of RNAs including a blind RNA-puzzle. The results are convincing and suggest that the improvements achieved by this new method are both significant and robust.

*Reviewer \#3*:

The determination of RNA structures has been challenging. While RNA molecules have evaded easy crystallization at a larger scale for a long time due to their highly charged backbone, structure predictions based sequence has gained large interest. Chemical probing of their structures has complemented these approaches. RNA molecules are comparably simple at the primary sequence and easily accessible to enzymatic and chemical manipulation followed by sequencing.

Cheng et al. present an experimental-computational multi-step pipeline that combines a mutate-and-map approach (M2) with a deep-sequencing based version of multiplexed hydroxyl radical cleavage analysis. The authors use this updated version in what they call a multidimensional chemical mapping (MCM) pipeline to determine a number of RNA structures. Some were known structures in the context of the RNA-puzzle challenge, in part done blindly. Using their pipeline Cheng et al. propose the structures of three riboswitches with and without their ligands and find that those two states are structurally much more similar than previously thought. Attempts to crystallize those switches without ligands may force the molecules into an undesired stable conformation and be non-physiological or these conformations might never result in well diffracting crystals. Lastly they propose a first structure for the human HoxA9D IRES, a cellular IRES implicated in the translational regulation of developmental patterning.

The authors describe an interesting experimental pipeline that may move the determination of RNA structures out of the hands of few specialized RNA biophysics labs into the hands of molecular biologists with access to deep sequencing equipment. The experimental method is relatively straightforward for anybody who has generated deep-sequencing libraries. Even though far from trivial, the adaptation of the protocol can provide a handle to address structural features at a larger scale which is very desirable in different fields of RNA biology.

The method is a further step in structure determination, but has only been verified on a very limited set of RNA structures. This makes some of the predictions difficult to assess. As an example: [Figure 2D](#fig2){ref-type="fig"} shows the refinement of P2.1 towards P4-P6. Other structural elements are not refined at all (purple loop). Why is that? Is a global RMSD score the best measure to describe the refinement of the structure? A wrong prediction of functionally critical residues may hamper the use of the method significantly. Can the authors use their data and compare whether the structural refinements are meaningful by focusing on the critical elements for their direct comparison? Due to the linearity of their sequencing approach the method can only detect cleavage that occurs 3\' of the •OH source. The authors themselves suggest, that circularization of the RNA might circumvent this issue but argue against it. This assumption may have major consequences on the quality of the prediction.

The manuscript is to a large extent the description of a new method. It is absolutely essential that the protocol is immediately applicable to different questions by different labs. In their Material and methods the authors are not consistent with the information they provide. It would be important if they provide information on how much material they recover at each step of the protocol (Post OH step, 3\'end repair, ligation...) as well as the reaction volumes of all steps (Results).

For the description of the riboswitch structures, I prefer to see the apo and the bound structure overlaid to form a better opinion on the extent of structural rearrangement of the two.

I do not feel competent to judge the computational assumptions that have been made by the authors to refine and translate the experimental results to steer the computational structure prediction (Methods).

10.7554/eLife.07600.027

Author response

*Specific comments*:

[*Figure 3 A, B*](#fig3){ref-type="fig"}*: The authors now explain the effects of oxidative damage far more clearly. Nevertheless, the very high frequency of additional RT stops could have a negative effect on the modeling, which the authors should discuss. First, by generating reads that are shorter than those arising from RT stops at site of the tether, they inflate the number of short pairwise constraints. It is still not clear to me that these do not bias the modeling procedure*.

The reviewer is correct that the high frequency of RT stops may cause attenuation of signal for pairs of residues that are far apart in the RNA sequence. Our analysis accounts for this type of attenuation, as described in the Results and Methods sections. We also present in the Methods section an experimental method to enrich long cDNA products and to rigorously combine sequencing data for these samples with non-enriched sequencing data (in the subsection headed 'Reverse transcription with sequencing primers (first adapter)').

For the lengths of RNAs probed in our study (up to 188 nucleotides in the region of interest), we were able to observe long-range hits throughout the proximity map, suggesting that our protocol was sufficient to correct for RT attenuation (see MOHCA-seq proximity maps, e.g. [Figure 3](#fig3){ref-type="fig"} and [Figure 3--figure supplement 3](#fig3s3){ref-type="fig"}). For longer RNAs that may be probed using MOHCA-seq in the future, RT attenuation may present a challenge for observing long-range proximities, in which case experimental adjustments to allow read-through of reverse transcription stopping events may need to be leveraged. We have added this point to the Discussion section:

"The experimental cost of MCM grows quadratically with the length of the transcript, limiting current analysis to domains of hundreds of nucleotides; however, \>1000-nt transcripts may become feasible as sequencing costs continue to decrease and if new strategies to bypass reverse transcription stops are implemented."

*Second, some of these reads could arise from two damaged sites 5\' of the tether, producing false constraints*.

We realize that our wording was unclear in describing these additional reads that may be due to reverse transcription termination at oxidatively damaged sites. The situation described by the reviewer, in which a strand scission event occurs 5´ of the tethered radical source and reverse transcription starting at that position terminates at a second oxidatively damaged site, should still reflect a 'true' constraint similar to constraints produced by strand scission and reverse transcription termination both occurring 3´ of the tethered radical source.

To clarify this point, we have added a panel to [Figure 2](#fig2){ref-type="fig"} (previously [Figure 3](#fig3){ref-type="fig"}) with a schematic illustration of the additional RNA fragments that are observable with MOHCA-seq compared to MOHCA-gel, by using 3´-end ligation to the RNA fragments and reverse transcription. We have also added a visualization-only 3D model of the proof-of-concept RNA with these types of hits illustrated on the structure ([Figure 2C](#fig2){ref-type="fig"}). We have also clarified our wording in the text, specifically in the legend for [Figure 2](#fig2){ref-type="fig"} and in the Results section. In the Results, we now state:

"Since these sites of reverse transcription termination marked locations that were also nearby in three dimensions to the radical source, the 5´ and 3´ ends of the resulting cDNAs would still be expected to report pairs of sites that were proximal in the RNA structure, albeit at longer average distances than source-to-cleavage pairs (illustrated in [Figure 2A](#fig2){ref-type="fig"})."

*In* [*Figure 3C, D*](#fig3){ref-type="fig"}*: Previous authors (e.g. Brenowitz et al.) reported a similar frequency of RT stops and strand cleavage, and not the 6-fold difference reported here. Could the authors comment on the reason for this difference? Is this because the authors use only ascorbate, rather than a combination of hydrogen peroxide and ascorbate? I am still puzzled by the claim that these additional RT stops arise from common base oxidation products, such as 8-oxoG or 5\'-HOC. Reverse transcriptases (and other DNA polymerases) are reported in the literature to bypass such lesions fairly easily*.

The exact oxidative lesions present in MOHCA-seq samples that result in RT stops are uncertain. Prior studies indicate that many oxidative modifications to RNA exist that have not been specifically demonstrated to permit or terminate reverse transcription, and the distribution of these modifications between ascorbate- and peroxide/ascorbate-mediated Fenton reactions has also not been characterized. Further experiments may help to identify the particular oxidative lesions that result in RT stops in MOHCA-seq experiments. We have edited the text regarding the reverse transcription-terminating modifications to indicate this (Results section):

"However, we were surprised to find additional stop sites beyond these source attachment positions ([Figure 2A](#fig2){ref-type="fig"}, right) \[...\] a model hairpin RNA with a single radical source attachment position ([Figures 2B-D](#fig2){ref-type="fig"})."

*In response to the reviewer comments, the authors provide better comparisons of models with and without the MOHCA constraints, but they didn\'t address how sensitive the models are to the number (and quality) of the constraints. If you leave out the* "*false*" *constraints, are the models better? If you include only half the number of* "*true*" *constraints, are the models significantly worse? This is certainly worth discussing and testing (if not now, in the future)*.

We agree with the reviewer that performing cross-validation, e.g. by leaving out subsets of constraints and testing whether these constraints are recovered by modeling, will be an important next step in improving the method. Such tests would include assessing the effects of 'true' or 'false' constraints, classified by comparison of the constraints to a crystallographic or other model, on the modeling accuracies. To emphasize this point, we have added text in the Discussion section:

"A fraction of observed MOHCA-seq constraints do not appear to reflect structures solved by crystallography; quantitative relationships correlating MCM data to structural features should further improve modeling accuracy and enable error estimation and cross-validation by leaving out constraints during modeling, analogous to continuing advances in NMR methods."

*The comparison of liganded and free riboswitches in* [*Figures 6 and 7*](#fig6 fig7){ref-type="fig"} *are a nice demonstration that the method is robust enough to give some kind of prediction even when the RNA is not stably folded. The conclusion that the models represent the actual ensemble of unliganded RNA conformations, however, is untested, and probably incorrect. The authors should remove this claim from the discussion and figure legends. It is easy to see from* [*Figure 6 and 7*](#fig6 fig7){ref-type="fig"} *that the uncertainty in modeling the unliganded riboswitches comes from a lack of constraints, rather than an increase in the average distance between RNA helices or a greater variety of constraints. Moreover, they necessarily obtain native-like structures in the absence of ligand, because these are the only structures that are sufficiently coherent to produce self-consistent constraints. (These two pitfalls are analogous to the well-understood limitations of 3D models based on NMR NOEs*.*)*

We thank the reviewer for this comment. To clarify that the models of the unliganded states of the riboswitch aptamers were used for initial visualization only, we have made edits to the Discussion and figure legends, as suggested by the reviewer:

Discussion: "MCM data corroborate and refine models of ligand-independent tertiary structure in a c-di-GMP riboswitch aptamer and reveals similarly preformed tertiary structure in glycine and AdoCbl riboswitch aptamers."

[Figure 4C](#fig4){ref-type="fig"} legend: "(c) Five MCM models with lowest Rosetta energy of c-di-GMP riboswitch aptamer give an initial visualization of ligand-free ensemble (left); modeling included pseudo-energy constraints from 0 µM c-di-GMP and 10 mM Mg^2+^ proximity map."

Similar edits were made to the legends for [Figures 5C, 5E, and 6B](#fig5 fig6){ref-type="fig"}.

For additional clarification, we also reiterate in the Results section (subsection headed "Direct nucleotide-resolution observation of preformed riboswitch aptamer tertiary structure using MCM") that the model ensembles shown for the unliganded riboswitch aptamers were used for initial visualization only:

"As in NMR studies of dynamic molecules, we therefore inspected an ensemble of models with the lowest Rosetta energy score instead of focusing on the cluster center*;* the resulting ensemble was used for initial visualization only. (Salmon et al., 2014, Bothe et al., 2011, Al-Hashimi, 2007)"

"As above, Rosetta modeling produced an initial visualization of a loose structural ensemble that samples, but does not stably remain in, the ligand-bound structure within the nanometer resolution of the MOHCA-seq method ([Figure 6B](#fig6){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"})."

\[Editors' note: the author responses to the previous round of peer review follow.\]

This is a major reworking of an article previously submitted to *eLife*. We received strong positive comments ('significant step forward', 'important advances...the results are convincing', 'very desirable in different fields of RNA biology') and detailed, valuable suggestions from three reviewers.

The reviewers' comments explicitly suggested moving several supporting sections with 'the substance of the paper' to the main text, which we have done. This has notably improved the clarity of the manuscript. Second, comments asking for more methodological details made us realize that we should have included several control experiments in the paper, especially on detailed quantitation of chemical modification events and on the accuracies of the 3D models without data. In fact, we had these measurements and calculations in hand but had previously left them out due to length concerns; they are now in the revised paper as main text figures. Third, comments from reviewers 2 and 3 on not feeling 'competent to judge the computational assumptions' made us realize that the original manuscript did not appropriately define our work's place in the lineage of hybrid computational/experimental approaches for RNA structure. We have now made major changes to the Title, Abstract, and Introduction to set our work in the context of classic and ongoing research in modelling molecules such as the group I ribozyme, for which global structures at 1-nm resolution have been powerful for fueling new experiments but not consistently attained for general RNAs. Along these lines, we should have suggested more reviewers with computational expertise.

Reviewer \#1:

*The authors describe an improved method for using high throughput sequencing and tethered hydroxyl radical cleavage to obtain distance constraints for RNA modeling. They offer an impressive array of successful examples, and also describe how the method is designed to work in tandem with their previously described mutate and map strategy for obtaining secondary structures. A large amount of work is presented in this paper. Although the pipeline is complicated and beyond the reach of most labs, it would represent a significant step forward, if it proves reliable over the long term*.

We thank the reviewer for their detailed assessment of our work. While we agree that our pipeline involves several steps for library preparation, we believe (as does reviewer \#3 below) that the method is not more complicated than RNA-seq and related protocols that are entering wide use, such as ribosome profiling (Ribo-Seq), crosslinking and immunoprecipitation sequencing (CLIP-seq), or crosslinking ligation and sequencing of hybrids (CLASH), and should be accessible to most labs.

*Below I outline some concerns about the presentation of the work and the basic premise of MOHCA-Seq*.

*The body of the manuscript is more of an advertisement than a description of what was done. The substance of the paper is in the Methods section, and the manuscript should be reorganized so that much more of the modeling strategy and data analysis is brought forward into the* "*Results*" *section.* [*Figure 1*](#fig1){ref-type="fig"} *and its supplements could be (ought to be) a substantial fraction of the* "*main*" *manuscript---this assessment is both a testament to the amount of work described in this paper, and a problem in that critical tests and examples of the method are buried*.

The previous version of the manuscript did not sufficiently describe the methods for data analysis and modeling, mainly because we were under the wrong impression that we needed to limit the length of the main text. Based on the reviewer suggestions (and our realization that *eLife* does not have an oppressive length limit), we have now reorganized the manuscript so that all methodological steps of data analysis and modeling---including newly presented controls (see below)---are now given in the main text. These moves include the following: [Figure 3](#fig3){ref-type="fig"} now presents MOHCA-seq data for a model hairpin RNA construct (previously [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}), with newly added quantification of strand scission and reverse transcription stop rates, as well as a comparison of MOHCA-seq and MOHCA-gel datasets (previously Figure 1--figure supplement 3) and a comparison of different nucleotide attachment sites for radical sources (previously Figure 1--figure supplement 6). These figures are also described in the Results section in the main text, which is notably clearer and more complete as a result.

*Although the authors present many success stories, they do not describe the statistics on how many models are correct, how dependent the final models are on individual constraints (what happens when one leaves some out?), and so on. To help the reader judge the importance of the 3D MOHCA constraints, comparisons in the supplemental Tables 3 and 4 should be brought into the main text and possibly illustrated*.

We agree that the importance of MOHCA-seq constraints could not previously be assessed upon reading the main text. To better illustrate the importance of the MOHCA-seq constraints, we now: (i) have incorporated modeling statistics (with and without MOHCA-seq data) from Supplementary files 3 and 4 into [Tables 1 and 2](#tbl1 tbl2){ref-type="table"} in the main text, (ii) show the results of modeling with and without MOHCA-seq data in main text [Figure 4](#fig4){ref-type="fig"} (previously [Figure 2](#fig2){ref-type="fig"}), (iii) have computed statistical significance values following the formulae of Hajdin, Weeks et al. and included these in [Table 1, and (iv)](#tbl1){ref-type="table"} made several text updates, including:

In the subsection headed "MOHCA-seq tertiary proximity map complements M^2^ secondary structure for Rosetta modeling of P4-P6": "Performing the same Rosetta modeling protocol without MOHCA-seq pairwise constraints led to a strikingly worse model with 38.3 Å accuracy to the crystal structure ([Figure 4A](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}), demonstrating that MOHCA-seq constraints are required for accurate modeling."

In the subsection "Multidimensional chemical mapping allows rapid modeling of diverse non-coding RNAs, including blind prediction challenges": "Again, we tested the necessity of MOHCA-seq data for completing the MCM pipeline by performing identical modeling of all ncRNA domains without MOHCA-seq constraints (M^2^/Rosetta modeling); just as for the P4-P6 domain, these runs produced dramatically less accurate models, as can be visually assessed ([Figure 4](#fig4){ref-type="fig"}) and quantitated by both RMSD to the crystallographic structure and statistical significance (Hajdin et al., 2010) ([Table 1](#tbl1){ref-type="table"})."

*A better discussion of the effects of noise, false distance constraints that arise from background cleavage of the RNA or other artifacts is needed*.

The effects of false distance constraints (MOHCA-seq hits that are inconsistent with the crystallographic structure in our benchmarks) were reported previously in our tables, which were provided as supplementary files, but they were not discussed thoroughly in the main text. We have added a better description of how noisy data are treated in signal processing:

Subsection "MOHCA-seq tertiary proximity map complements M^2^ secondary structure for Rosetta modeling of P4-P6": "Additionally, the digital form of MOHCA-seq data enabled rigorous analysis to resolve further features. \[...\] we apply a two-dimensional smoothing algorithm to produce the final proximity map for visualization ([Figure 2--figure supplement 1C](#fig2s1){ref-type="fig"})."

The false constraints appear reproducibly even after data averaging and this COHCOA analysis, suggesting that they are not due to noise. A remaining hypothesis, which we favor, is that these constraints are due to conformational fluctuations in the RNA structure and/or in the linkers. To better discuss effects of false constraints, we have included these fractions of unobeyed constraints in [Table 2](#tbl2){ref-type="table"} and added discussion in the main text:

Subsection "MOHCA-seq tertiary proximity map complements M^2^ secondary structure for Rosetta modeling of P4-P6": "For the P4-P6 benchmark case, we found that the cluster center of the MCM pipeline had an accuracy of 8.6 Å RMSD to the crystal structure ([Figures 2F and 4A](#fig2 fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). This suggests that MCM is capable of defining the global 3D structure of the RNA, without any crystallographic information, at near the resolution of a register shift (6 Å) even when weak MOHCA-seq features not explained by the crystal structure are used to constrain modeling."

Subsection "Multidimensional chemical mapping allows rapid modeling of diverse non-coding RNAs, including blind prediction challenges": "The lack of correlation between the fraction of satisfied MOHCA-seq pairwise constraints and the accuracy of the models ([Table 2](#tbl2){ref-type="table"}) \[...\] as has been observed in prior macromolecule modeling based on pairwise information. (Das et al. 2008, Thompson et al. 2012, Bowers et al. 2000)"

In addition, we have added a significant amount of main text to discuss the possibility of long-distance hits due to linker blurring (see response below on correlative oxidative damage pairs) as well as conformational flexibility (see responses to reviewer 2 below).

*My main concerns have to do with the distribution of the MOHCA-Seq reads and their interpretation as* "*distance constraints*"*. In the main text (and supplement), the authors note that they observe additional sequence reads from arrest of RT at damaged (oxidized) nucleotides that lie between the radical source and the site of cleavage. First, the authors assume these* "*extra*" *stops arise from non-scissile base damage, but of course, they could arise from strand scission events. The authors write as if these are in different categories, but this distinction is meaningless as the reason for the RT stop can\'t be ascertained after the fact*.

We agree that our language and experimental assessment of the types and extent of oxidative damage were unclear, but are very important for establishing the proposed method. The reviewer's comments have led us to include additional experimental controls that quantitated the extent and sequence dependence of damage (we had these in hand from our pilot work but did not include them previously). For example, we observed similar results from both capillary electrophoresis and sequencing analysis that the total amount of RT- stopping damage exceeds scissile backbone damage by at least 6-fold. These results are presented in the new [Figure 3](#fig3){ref-type="fig"}. Concomitantly we have expanded the main text to include more complete discussion of damage mechanisms, and references to the extensive work on radical damage on nucleic acids:

Subsection "Deep proximity maps of ncRNA 3D structure from single experiments": "We expected reverse transcription to then stop at the nucleotide tethered to the bulky radical source at its C2´ position \[...\] the 5´ and 3´ ends of the resulting cDNAs still reported pairs of sites that were proximal in the RNA structure, albeit at somewhat longer distances than source-to-cleavage pairs."

*In* [*Equation 4*](#equ4){ref-type="disp-formula"}*, are the authors simply attempting to model the distribution of their data as arising from a component that depends on the frequency of tethered Fe(II)-EDTA complexes and a component that is independent of having tethered complexes? I presume this is the idea behind the COHCOA correlation analysis, which rightly ignores the distinction between* "*oxidative damage*" *and* "*cleavage*"*. This could be explained more forthrightly*.

The reviewer is correct on this point, and we have amended our language to make this clearer:

Subsection "Closure-based •OH COrrelation Analysis (COHCOA)": "The effects of the radical cleavage result in a one-dimensional damage profile *R*~*i*~ (corresponding to uncorrelated oxidative damage) and cleavage profile *B*~*j*~ and a two-point correlation function *Q*~*ij*~ (corresponding to correlated oxidative damage or radical source locations) which encodes the desired proximity map"

*On the other hand, as the total dose of Fe(II)EDTA-dependent hydroxyl radical cleavage increases, the frequency of stops at a cleaved residue will equal or exceed RT stops at the site of the tether. In this limit, any information about the pairwise correlation between the site of the tethered reagent and the site of cleavage will be lost, undermining the premise of the experiment. At what limit does this occur, and does this tendency already account for the very uniform map before COHCOA analysis*?

The described effect of overmodification by radicals does not actually occur; we did not explain this well in the original paper. In our experiments, ascorbate-induced, spatially localized oxidative damage appears to be 'self-limiting'; the correlated signal in MOHCA-seq datasets remains visible even after 30 minutes of incubation with ascorbate, which is three times our standard reaction time of 10 minutes, without a rising background. Based on separate electrophoresis experiments on the ascorbate-activated RNA and model constructs, the self-limitation appears to be due to the radical source cleaving itself off the RNA after some time. Although we previously described this mechanism in our MOHCA-gel paper, we neglected to discuss this in the original submission. We have added discussion of this point to the main text:

Subsection headed "MOHCA-seq tertiary proximity map complements M^2^ secondary structure for Rosetta modeling of P4-P6": "To test the robustness of the protocol, we varied several experimental parameters \[...\]. Capillary electrophoresis of ascorbate-treated end-labeled RNA supported this mechanism of self-limiting the reaction; see also ref (Das et al. 2008)."

*Even when cleavage events are sparse, I had trouble understanding how the authors turn the distribution of RT stops into reliable distance constraints. Backbone cleavage arising from a tethered source of hydroxyl radical can be interpreted as a (blurred) vector between two residues. By contrast, sequence reads that start and end at two damaged or cleaved sites may arise when both residues are close to the radical source. However, one cannot be sure how close the sites are to each other, especially as one does not know where the Fe-EDTA was tethered. Presumably the inconsistencies arising from such ambiguities in the distance constraints are sorted out during the modeling, but what evidence do the authors have that this is the case*?

The reviewer is correct: the location of a radical source that causes two correlated oxidative damage events that are both 3´ of the radical source's location, one of which terminates a reverse transcription product that started at the other position, is not reported by the resulting cDNA. Such pairs of oxidative damage events are nevertheless still correlated by virtue of each being correlated to the radical source location, but their spatial distances will be blurred compared to direct source-scission events. It was a working hypothesis that these distances would still allow accurate global structure modeling; our original language did not make this clear. We have added discussion of this point to the text:

Subsection entitled "Deep proximity maps of ncRNA 3D structure from single experiments": "Since these sites of reverse transcription termination marked locations that were also nearby in three dimensions to the radical source \[...\] this significantly larger number of pairwise proximities would permit rapid ncRNA modeling with comparable accuracy to the prior method ([Figure 3E-F](#fig3){ref-type="fig"})."

As the reviewer indicates, we suspected that the inconsistencies in a set of many pairwise MOHCA-seq constraints would be sorted out by highly-sampled Rosetta modeling, as it was in the previous MOHCA-gel study. Here, we found that we were able to recover the 3D structures of our benchmark RNAs even though some MOHCA-seq constraints were not satisfied by our final models. We have added discussion of this point in the subsection "Multidimensional chemical mapping allows rapid modeling of diverse non-coding RNAs, including blind prediction challenges", as quoted in our response to an earlier point.

*In the modeling section, it is stated that 60%-80% of constraints were satisfied by the best models; to what degree does this reflect the level of cleavage or specific types of non-random noise (see below)*?

As described in an above response, we observed that the level of correlated cleavage in the MOHCA-seq reaction is self-limiting, and as noted in our next responses, the non-random two-dimensional background arising from uncorrelated oxidative damage is removed by the COHCOA analysis and, for a few noise features, by averaging experimental replicates. So we believe the percentage of constraints satisfied is likely not related to this uncorrelated background but instead to alternative conformational states or inconsistent pairwise constraints arising from signal due to double oxidative damage events, as discussed in the previous response and in our revised text in "Multidimensional chemical mapping allows rapid modeling of diverse non-coding RNAs, including blind prediction challenges".

[*Equation 3*](#equ3){ref-type="disp-formula"} *assumes a uniform rate of background cleavage* b~j~*. Of course, the background cleavage is almost certainly non-uniform. It is well known that certain residues will be more prone to hydrolysis (or RNase digestion) than others, and the resulting distribution of reads will appear similar to a genuine signal from a tethered Fe(II)EDTA*.

Our previous language describing a "uniform rate of background cleavage" was unclear. We have updated the language to clarify that the background cleavage *b*~*j*~ is not uniform along the sequence of an RNA molecule but is independent of and uncorrelated with any specific radical source:

In the subsection headed "General MOHCA-seq analysis framework": "First, we assume that the cleavage fraction that allows ssDNA adapter ligation, $q_{j}^{s}$ is composed of a 'background' rate of cleavage *b*~j~ that is independent of source *s* but can vary with nucleotide j (e.g., due to inline attack during the fragmentation reaction), and additional, correlated cleavage due to hydroxyl radical-induced strand scission events (the desired MOHCA-seq signal), parameterized by $\pi_{j}^{s}$:

$$\text{Cleavage at }j\text{ from source }\mathit{s} = q_{j}^{s} = 1 - \left( {1 - b_{j}} \right)\left( {1 - \pi_{j}^{s}} \right) \approx b_{j} + \pi_{j}^{s}$$~"~

*Is this type of non-random background addressed by using a mock-treated control? How is the information from the control incorporated into the data analysis? It would be great to see examples of data sets in which the iron was left out, or data sets on a long double-stranded RNA, and so on, to get an idea of how well the method works in these idealized or control examples*.

We hope that our updated language for the previous response clarifies that the COHCOA analysis is explicitly formulated to account for this type of non-random background.

In terms of controls, a standard part of the MOHCA- seq experiment is to carry out the full protocol on a sample that is not treated with ascorbate, in parallel with the ascorbate-treated (fragmented) sample; this is similar to a mock-treated control where Fe(III) is not loaded on the tethered ITCB-EDTA. This control is to ensure that signal that we observe in the ascorbate-treated samples does not occur independent of radical source activation, but we do not directly use the control data in our analysis because COHCOA accounts for such non-random background. A control sample treated with ascorbate but without tethered radical sources is shown in [Figure 3--figure supplement 1A](#fig3s1){ref-type="fig"}, and a control sample with tethered radical sources but not treated with ascorbate is shown in [Figure 3--figure supplement 2A](#fig3s2){ref-type="fig"}, and they are referenced in the legend for [Figure 3](#fig3){ref-type="fig"}.

*Finally, a drawback of the original MOHCA was that the experimentally observed constraints were all short range with respect to the RNA sequence. A cutoff was applied so that these short-range constraints did not overwhelm the model building. A similar strategy is presumably used here: how sensitive are the models to this cutoff*?

The cutoffs for determining MOHCA constraints were not clear in the original manuscript. Briefly, the large background for short sequence separations (the black 'diagonals' in presented maps) prevented use of MOHCA-seq constraints for short sequence separations. Further, given the accuracy of the newly available mutate-and-map protocol for inferring secondary structure, we sought to only use MOHCA-seq to determine tertiary proximities for nucleotide pairs that are far in secondary structure. The discussion of this constraint determination has been significantly expanded in the main text:

Subsection headed "MOHCA-seq tertiary proximity map complements M^2^ secondary structure for Rosetta modeling of P4-P6": "First, to reduce the computational expense of sampling helices \[...\] Therefore, we used all data, including the few weak features not explained by the crystal structure (pink circles, [Figure 2D](#fig2){ref-type="fig"})."

*And what is the practical limit on the size of the RNA that can be modeled by this method*?

We have noted the practical limit on the sizes of RNAs that can be addressed by the MCM pipeline in the Discussion:

"The experimental cost of MCM grows quadratically with the length of the transcript, limiting current analysis to domains of hundreds of nucleotides; however, \>1000-nt transcripts may become feasible as sequencing costs continue to decrease."

Reviewer \#3:

*The determination of RNA structures has been challenging. While RNA molecules have evaded easy crystallization at a larger scale for a long time due to their highly charged backbone, structure predictions based sequence has gained large interest. Chemical probing of their structures has complemented these approaches. RNA molecules are comparably simple at the primary sequence and easily accessible to enzymatic and chemical manipulation followed by sequencing*.

*Cheng et al. present an experimental-computational multi-step pipeline that combines a mutate-and-map approach (M2) with a deep-sequencing based version of multiplexed hydroxyl radical cleavage analysis. The authors use this updated version in what they call a multidimensional chemical mapping (MCM) pipeline to determine a number of RNA structures. Some were known structures in the context of the RNA-puzzle challenge, in part done blindly. Using their pipeline Cheng et al. propose the structures of three riboswitches with and without their ligands and find that those two states are structurally much more similar than previously thought. Attempts to crystallize those switches without ligands may force the molecules into an undesired stable conformation and be non-physiological or these conformations might never result in well diffracting crystals. Lastly they propose a first structure for the human HoxA9D IRES, a cellular IRES implicated in the translational regulation of developmental patterning*.

*The authors describe an interesting experimental pipeline that may move the determination of RNA structures out of the hands of few specialized RNA biophysics labs into the hands of molecular biologists with access to deep sequencing equipment. The experimental method is relatively straightforward for anybody who has generated deep-sequencing libraries. Even though far from trivial, the adaptation of the protocol can provide a handle to address structural features at a larger scale which is very desirable in different fields of RNA biology*.

*The method is a further step in structure determination, but has only been verified on a very limited set of RNA structures. This makes some of the predictions difficult to assess*.

We wish to note that the presented benchmark, with 6 'benchmark' RNAs of known structure and 4 cases with unknown (but interesting) structure, is at a larger scale than prior studies introducing new experimental methods (including our own MOHCA-gel paper and recent 3D approaches based on NMR). It also includes a blind test, which provides rigorous assessment, and is unusual in modeling.

*As an example:* [*Figure 2D*](#fig2){ref-type="fig"} *shows the refinement of P2.1 towards P4-P6. Other structural elements are not refined at all (purple loop). Why is that? Is a global RMSD score the best measure to describe the refinement of the structure? A wrong prediction of functionally critical residues may hamper the use of the method significantly. Can the authors use their data and compare whether the structural refinements are meaningful by focusing on the critical elements for their direct comparison*?

We agree with the reviewer that a global RMSD score is not the best representation of the refinement of the lariat-capping ribozyme model, and we have thus added the RMSDs over the refined elements (P2.1 and P4-P6) from MCM and M^2^/Rosetta modeling to the figure legend ([Figure 4F](#fig4){ref-type="fig"}), in addition to stating their modeling results and statistics in [Tables 1 and 2](#tbl1 tbl2){ref-type="table"}.

*Due to the linearity of their sequencing approach the method can only detect cleavage that occurs 3\' of the •OH source. The authors themselves suggest, that circularization of the RNA might circumvent this issue but argue against it. This assumption may have major consequences on the quality of the prediction*.

We have removed this text, as it was confusing. Circularization will not be generally applicable to any RNA domain, but may enhance the information content for cases that can be circularized; we are testing this procedure now but the results are beyond the scope of this study.

*The manuscript is to a large extent the description of a new method. It is absolutely essential that the protocol is immediately applicable to different questions by different labs. In their Material and methods the authors are not consistent with the information they provide. It would be important if they provide information on how much material they recover at each step of the protocol (Post OH step, 3\'end repair, ligation...) as well as the reaction volumes of all steps (Results)*.

We thank the reviewer for pointing out these omissions. We have added these details to the Materials and methods section, including estimated yields for each step.

*For the description of the riboswitch structures, I prefer to see the apo and the bound structure overlaid to form a better opinion on the extent of structural rearrangement of the two*.

We now show the ligand-bound crystallographic structures next to the MCM models of unbound riboswitches, in the same orientation, in the figures depicting these comparisons ([Figures 5-7](#fig5 fig6 fig7){ref-type="fig"}). We tried overlaying the structures but found that it was difficult to make the visual comparison.

[^1]: MCM modeling was performed with MOHCA-seq constraints from data sets collected on the ligand-bound state; ligands were not included during Rosetta modeling.

[^2]: M^2^/Rosetta statistics are reported for RNA-puzzle submission rank 1 models, which included subdomains built by homology modeling.

[^3]: Calculated over core domain residues or refined regions after alignment using MAMMOTH; ([@bib54]) see 'Materials and methods'.

[^4]: p-value computed using analytical formula for secondary-structure-constrained 3D modeling in ref. ([@bib32]); it is not applicable to peripheral domains. Values above 0.9 are not well-determined and are presented as \> 0.9.

[^5]: MCM: multidimensional chemical mapping; RMSD: root-mean-squared-deviation.

[^6]: Constraints were considered satisfied if the O2′ of the 5′-residue was less than 30 Å from the C4′ of the 3′-residue ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}).

[^7]: For ligand-free states of the adenosylcobalamin riboswitch aptamer, cyclic-di-GMP riboswitch aptamer, and glycine riboswitch ligand-binding domain, RMSDs and percent constraints satisfied were calculated for gold-standard crystal structures solved in the presence of ligand.

[^8]: For states not expected to agree with crystal structures, RMSD accuracy is given in parentheses.

[^9]: No strong constraints were selected for the unbound state of the glycine riboswitch ligand-binding domain without leader sequence.

[^10]: Three separate modeling runs were performed for each ligand-binding state of the riboswitch aptamer, using distinct sets of prebuilt fragments prepared for RNA-puzzle 6; see 'Materials and methods'. The number of models, size of largest cluster, cluster center RMSD (accuracy), and constraint satisfaction percentages are representative data from the modeling run with the most models generated. The intra-cluster RMSD used to estimate the in situ RMSD is calculated as the mean pairwise RMSD between the cluster centers of the top cluster from each of the three modeling runs.

[^11]: Calculated over refined regions or core domain residues after alignment using MAMMOTH; ([@bib54]) see 'Materials and methods'.

[^12]: MCM: multidimensional chemical mapping; RMSD: root-mean-squared-deviation.
